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Vibrio vulnificus, a Gram-negative halophile which is ubiquitously present in the marine 
environments, can cause diseases like gastroenteritis, septicemia and wound infections in 
susceptible human beings. Production of capsular polysaccharide results in an opaque phenotype, 
which is pathogenic to humans. Loss or reduction of capsule results in translucent colonies 
composed of cells that are nonpathogenic or have diminished virulence, respectively. The opaque 
and the translucent phenotypes, upon production of an exopolysaccharide, give rise to a dry, 
wrinkled rugose form that can form copious biofilms. These three phenotypes can spontaneously 
switch from one form to another in a process known as phase variation. In this study, we have 
sought to identify environmental factors and genetic mechanisms that affect phase variation and 
biofilm formation in V. vulnificus. Elements such as Ba2+, Mn2+, and Sr2+, were tested to determine 
their effect on V. vulnificus phase variation and we found that manganese at micromolar to 
millimolar concentrations, induces V.vulnificus polysaccharide phase variation from opaque to 
translucent or rugose forms in this species. Since calcium was previously shown to induce 
significant phase variation in different V.vulnificus strains, we have also attempted to compare the 
effects of equimolar addition of manganese and calcium on phase variation of different 
V.vulnificus strains. Here, we have also attempted to better understand the process of V. vulnificus 
rugose colony formation. Our study has identified 28 proteins that include translational elongation 
factors, various metabolic enzymes, proteases, sugar binding proteins, amino acid transporters, 
polar flagellins and an uncharacterized protein that are differentially expressed in the biofilm 
proficient rugose phase variant compared to the parent isogenic opaque phase variant. One protein 






identified as being expressed at higher amounts, and concomitantly showed higher transcript levels 
in the rugose variant compared to the opaque variant. Interestingly, generation of a targeted mutant 
of the malE gene did not knock out rugosity, indicating that the malE (VVA0397) gene is not 
required for rugosity in V.vulnificus. However, its up-regulation at both the transcriptional and 
translational levels suggests that MalE protein is involved in rugose colony formation in a way 


















It was in 1883 that Koch first cultured V. cholerae from epidemics in India and Egypt 
(Thompson, Iida et al. 2004). It was then that intensive studies were undertaken to identify and 
differentiate pathogenic vibrios from the nonpathogenic ones (Farmer and Hickman-Brenner 
2006). Then in the late 1940’s, Fujino isolated V. parahaemolyticus from a food poisoning 
outbreak in Oaska, Japan (Fujino, Resources et al. 1974). Later on in 1976, Hollis et al., reported 
the isolation of a bacterium from blood samples that was similar to V. parahaemolyticus, but 
differed from other vibrios, and was able to ferment lactose, and required salt for its growth (Hollis, 
Weaver et al. 1976). This bacterium was called Beneckea vulnifica by Reichelt et al. (Reichelt, 
Baumann et al. 1976), but as this nomenclature was not widely accepted, it was finally renamed 
Vibrio vulnificus by Farmer et al. (Farmer 1979). 
Vibrio vulnificus is a Gram-negative, motile, curved bacillus, naturally occurring in coastal, 
estuarine and marine environments around the world (Tamplin, Rodrick et al. 1982, Myatt and 
Davis 1989, Maxwell, Mayall et al. 1991, O'Neill, Jones et al. 1992, Veenstra, Rietra et al. 1994, 
Dalsgaard, Frimodt-Moller et al. 1996, Wright, Hill et al. 1996, Hoi, Larsen et al. 1998, Shapiro, 
Altekruse et al. 1998). In these environments, V. vulnificus exists freely in the water columns and 
sediments, also attaches to plankton and moreover is concentrated in seafood such as the guts of 
filter feeding mollusks including shrimp, lobsters and oysters (Elmore, Watts et al. 1992, DePaola, 
Capers et al. 1994, do Nascimento, dos Fernandes Vieira et al. 2001, Baffone, Tarsi et al. 2006, 
Mahmud, Neogi et al. 2008). V. vulnificus is a halophile which can survive in salinities ranging 
from 15 to 25 parts per thousand (Motes, DePaola et al. 1998) and temperatures ranging from 10 






(VBNC) state in which the bacteria are alive but cannot be immediately cultured (Oliver, Warner 
et al. 1982, Kaysner, Abeyta et al. 1987, Oliver, Hite et al. 1995). Resuscitation from the VBNC 
state occurs in warmer temperatures within 7-10 days (Oliver and Bockian 1995).  
Six strains of V. vulnificus have been sequenced (Gulig, de Crecy-Lagard et al. 2010) and 
sequencing of additional genomes is underway   
(http://www.ncbi.nlm.nih.gov/genome/genomes/189).  The total genome size so far ranges from 
4.33 to 5.75 Mb. The genome of V. vulnificus is made up of two circular chromosomes, a larger 
one ranging from 3.19 to 3.35 Mb and a smaller one ranging from 1.81 to 1.85 Mb. The GC % in 
different strains ranges from 44.9 to 47. The number of genes range from 4,572 to 5,166 and the 
number of proteins range from 4,433 to 5,023 (Chen, Wu et al. 2003, Kim, Lee et al. 2003, Park, 
Cho et al. 2011) (http://www.ncbi.nlm.nih.gov/genome/genomes/189).  
Vibrio vulnificus has the highest fatality rate of any seafood pathogen and deaths occur in 
50 % of the cases after the onset of disease (Oliver 2013). As reviewed previously by Jones and 
Oliver (Jones and Oliver 2009), infections are more common in the warmer months of May through 
October. The concentration of V. vulnificus in raw oysters can reach as high as 1 x 103 to 1 x 106 
bacteria per gram of oyster meat in the warm summer months in the Gulf of Mexico (Tamplin, 
Rodrick et al. 1982, Wright, Hill et al. 1996, Motes, DePaola et al. 1998). Males are more 
susceptible to infection compared to females due to the protective action of estrogen against 
endotoxic shock (Merkel, Alexander et al. 2001). Consumption of raw oysters by people with 
preexisting medical conditions, such as hemochromatosis, which is an iron imbalance in the body, 
diabetes, liver cirrhosis, alcoholism, kidney problems and immunocompromised systems, renders 






and Hogan 1992, Hlady and Klontz 1996, Kumamoto and Vukich 1998, Gulig, Bourdage et al. 
2005), which are characterized by fever, chills and hypotensive septic shock (Chuang, Yuan et al. 
1992, Hlady and Klontz 1996, Klontz, Lieb et al. 1988, Strom and Paranjpye 2000). Also exposure 
of skin abrasions to contaminated seafood drippings or seawater can result in wound infections 
that may require tissue debridement, skin grafts or even limb amputation in very severe cases 
(Hollis, Weaver et al. 1976, Gulig, Bourdage et al. 2005). Even with treatment, mortality in case 
of septicemia can be 75 % and that in case of wound infections can be as high as 50 % (Hlady and 
Klontz 1996).  
As reviewed by Jones and Oliver (Jones and Oliver 2009), the US Food drug and 
administration (FDA) has reported an average of 34 cases of infection annually caused by V. 
vulnificus. Also, data from the Centers for Disease Control and Prevention (CDC) has indicated 
that the number of V. vulnificus cases is progressively increasing over the years. Between 1996 
and 2006 there was a 76 % increase in V. vulnificus cases. This increase in the number of V. 
vulnificus infections may be related to global warming leading to higher water temperatures (Paz, 
Bisharat et al. 2007). Wound infections in particular have been on the rise in the US (Craig, Joaquin 
et al. 2012). Even though the number of V. vulnificus cases recorded are on an increase, and the 
actual number of deaths caused by V. vulnificus are low, the opportunistic nature of this bacterium 
poses a risk to nearly 12-30 million American people who have at least one of the several 
predisposing conditions mentioned previously (Jones and Oliver 2009). This disparity in the 
number of infections caused by V.vulnificus and the number of susceptible individuals, hints 
towards the fact that the majority of the strains in the environment are not pathogenic (Oliver 






strains are better at forming marine aggregates, which are better taken up by oysters compared to 
clinical (C) genotype strains (Froelich, Ayrapetyan et al. 2013).  
Several virulence factors, such as capsule (Amako, Okada et al. 1984, Yoshida, Ogawa et 
al. 1985, Simpson, White et al. 1987, Wright, Simpson et al. 1990), iron acquisition systems 
(Wright, Simpson et al. 1981, Simpson and Oliver 1983), flagella (Ran Kim and Haeng Rhee 2003, 
Lee, Rho et al. 2004, Natividad-Bonifacio, Fernandez et al. 2013, Kim, Thanh et al. 2014), pili 
(Paranjpye, Lara et al. 1998, Paranjpye and Strom 2005, Horseman and Surani 2011, Natividad-
Bonifacio, Fernandez et al. 2013), hemolysins - cytolysins (Johnson and Calia 1981, Kreger and 
Lockwood 1981, Gray and Kreger 1985, Yamamoto, Wright et al. 1990, Wright and Morris 1991, 
Kook, Lee et al. 1996, Natividad-Bonifacio, Fernandez et al. 2013), metalloproteases (Miyoshi, 
Hirata et al. 1994, Chuang, Sheu et al. 1997, Chang, Kim et al. 2005, Shinoda 2005, Shinoda and 
Miyoshi 2011, Miyoshi 2013), RtxA toxin (Lee, Kim et al. 2007, Lee, Choi et al. 2008, Lee, Lee 
et al. 2008, Kwak, Jeong et al. 2011, Lo, Lin et al. 2011, Kim, Lee et al. 2013, Natividad-Bonifacio, 
Fernandez et al. 2013) and lipopolysaccharide (LPS) (McPherson, Watts et al. 1991), have been 
reported; however, of all these, the capsule is considered to be the major virulence factor (Jones 
and Oliver 2009).  
Numerous studies have been devoted to identifying the differences between environmental 
and clinical V. vulnificus isolates. V. vulnificus has been classified based on biotypes, antigens, 
capsule composition, LPS composition and genetic sequences (Gulig, Bourdage et al. 2005). 
Biochemically, V. vulnificus has been divided into 3 biotypes (Bisharat, Agmon et al. 1999). 
Biotype 1 strains are human pathogens, and are indole and ornithine decarboxylase positive. 






3 strains are human pathogens isolated as yet only from Israel, and are indole and ornithine 
decarboxylase positive. Biotype 1 strains are heterogeneous in their LPS composition based on 
their reaction to LPS monoclonal antibodies (Martin and Siebeling 1991). In contrast, biotype 2 
strains possess only one type of LPS (Biosca, Oliver et al. 1996).  Since the capsule is considered 
to be the major virulence marker in V. vulnificus infections, a number of studies have been 
performed to distinguish the clinical and environmental strains based on their capsule type. 
Carbohydrate analysis of clinical and environmental strains revealed that capsular carbohydrate 
composition was very heterogeneous among the strains studied (Hayat, Reddy et al. 1993, Bush, 
Patel et al. 1997). Based on the results from the LPS and capsular polysaccharide (CPS) 
composition analysis, any correlation with the CPS or LPS type and less virulent (e.g. 
environmental) vs. more virulent (e.g. clinical) strains could not be established.  
A number of genotyping approaches have also been undertaken to distinguish virulent 
versus non-virulent V. vulnificus strains. Randomly amplified polymorphic DNA – polymerase 
chain reaction (RAPD-PCR) identified the presence of a virulence correlated gene (vcg) in human 
clinical isolates but it was generally absent from environmental strains isolated from water (Warner 
and Oliver 1998). Further studies comparing the ‘vcg’ gene sequence from clinical and 
environmental strains identified allelic differences between the sequences. Alleles specific to the 
clinical and the environmental strains were termed as vcgC and vcgE, respectively (Rosche, Yano 
et al. 2005). Differences in restriction fragment length polymorphism (RFLP) of the 16S rRNA 
genetic sequences have also been used to distinguish between clinical and environmental isolates. 
In this case, environmental isolates were designated ‘A’ type and clinical isolates were designated 






spacer region (ISR1) between the 16S rRNA and the 23S rRNA genes demonstrated that two 
groups of strains exist: one containing clinical, 16 S rRNA RFLP profile B strains, while the other 
group contained only the environmental 16 S rRNA A-type strains (Gonzalez-Escalona, Jaykus et 
al. 2007). Multilocus sequence typing (MLST) of 6 housekeeping genes divided V. vulnificus 
strains into two lineages: lineage I, which contained biotype 1 strains, and lineage II, which 
contained biotype 1 and 2 strains; however, the proportion of clinical isolates was higher in lineage 
I than in lineage II (Cohen, Oliver et al. 2007). Furthermore, it was also shown that 16S rRNA 
RFLP profile A strains, have allele 2 of the type I CPS operon while 16S RFLP profile B strains 
have allele 1 (Chatzidaki-Livanis, Hubbard et al. 2006, Chatzidaki-Livanis, Jones et al. 2006, 
Cohen, Oliver et al. 2007).  
Subsequently, genomes of four V. vulnificus strains were compared by SOLiD sequencing, 
which grouped 2 clinical strains in Clade 2 and two environmental isolates in Clade 1. This study 
detailed a number of genes unique to the each of the clades and also revealed that Clade 2 possessed 
more virulence potential than Clade 1. (Gulig, de Crecy-Lagard et al. 2010). Pyrosequencing of 3 
environmental V. vulnificus strains and their comparison to genomes of 3 sequenced clinical V. 
vulnificus strains have identified 167 genes to be exclusively associated with E genotype and 278 
genes associated with the C genotype (Morrison, Williams et al. 2012). Strains with the E 
phenotype had a significant enrichment of genes functioning in urea, nitrogen metabolism and 
proteins involved in chitin hydrolysis, while strains with the C genotype had genes involved in 
sialic acid (neuraminic acid derivatives) metabolism, type IV secretory pathway and unique cyclic 
di GMP proteins (Morrison, Williams et al. 2012). However, none of the aforementioned studies 






Production of the major virulence factor, CPS, by V. vulnificus, results in opaque colonies 
on agar surfaces that appear smooth, shiny and mucoid (Amako, Okada et al. 1984, Yoshida, 
Ogawa et al. 1985, Simpson, White et al. 1987).  Cells in these opaque colonies are able to kill an 
iron loaded mouse at an LD50 (lethal dose required to kill 50 % of the test population) value of as 
low as one cell (Zuppardo and Siebeling 1998). Loss or reduction of capsular material  results in 
translucent colonies (Yoshida, Ogawa et al. 1985, Simpson, White et al. 1987, Wright, Simpson 
et al. 1990), or colonies with an intermediate phenotype (Chatzidaki-Livanis, 2006, Rosche, 2006). 
Cells in translucent or intermediate colonies are attenuated for virulence as pathogenicity 
correlates to the amount of capsule production (Amako, 1984, Yoshida, 1985, Wright, 1990, 
Zuppardo, 1998, Wright, 2001, Grau, 2005). A number of studies have reported that some 
translucent V. vulnificus  strains are not virulent enough to kill an iron overloaded mouse, even at 
relatively high CFU’s (Amako, Okada et al. 1984, Yoshida, Ogawa et al. 1985, Wright, Simpson 
et al. 1990, Zuppardo and Siebeling 1998, Wright, Powell et al. 2001, Grau, Henk et al. 2005). 
Both the opaque and the translucent phenotypes, upon production of a separate exopolysaccharide 
(EPS), give rise to rugose colonies, which appear dry and wrinkled on agar surfaces. Rugose cells 
can form profuse biofilms (Grau, Henk et al. 2005), and may be pathogenic only if derived from 
an encapsulated parent (Grau, Henk et al. 2008). The opaque, translucent and rugose phenotypes 
possess the capability to spontaneously switch from one phenotype to the other by the loss or gain 
of expression of surface polysaccharides, and this process is referred to as phase variation (Grau, 
Henk et al. 2005). Phase variation is defined as the reversible change in phenotype caused by 
genetic or epigenetic changes that aid in the survival or adaptation of different organisms (van der 






bacteria have been reported to occur at the rate of 1 in 108 cells per generation, phase variation 
occurs at a much higher frequency of 1 in 103 cells per generation or greater (Salaun, Snyder et al. 
2003, van der Woude and Baumler 2004).  
Several studies have elucidated environmental and genetic causes that form the basis of 
phase variation. Surface structures such as proteins, pili, fimbriae, flagella, LPS, capsule and 
exopolysaccharides have been shown to undergo phase variation in different organisms (van der 
Woude and Baumler 2004). A number of environmental influences triggering phase variation have 
been documented as well. For example, pili in Neisseria gonorrhoeae undergo increased frequency 
of phase variation due to iron starvation (Serkin and Seifert 2000). Temperature, pH, carbon source 
and amino acid concentration affect fimbrial phase variation in Escherichia coli and Salmonella 
typhimurium (van der Woude and Baumler 2004). Also, various genetic mechanisms such as site 
specific recombination, homologous recombination, insertions, deletions and slipped strand 
mispairing as well as epigenetic mechanisms such as methylation have been identified to be the 
underlying basis of phase variation in different organisms (van der Woude and Baumler 2004, 
Wisniewski-Dyé and Vial 2008). 
Since the presence of capsule in V.vulnificus, directly correlates with the ability to cause 
human diseases, a lot of work has been focused on identifying the genes involved in capsule 
biosynthesis and, importantly, the factors that bring about a switch from the opaque virulent to the 
translucent avirulent phenotype. The capsule provides resistance to opsonization by complement 
and therefore prevents phagocytosis by macrophages (Tamplin, Specter et al. 1983, Tamplin, 
Specter et al. 1985, Yoshida, Ogawa et al. 1985, Kashimoto, Ueno et al. 2003). In addition, the 






nonspecific responses in the host (Yoshida, Ogawa et al. 1985, Roberts 1996, Kashimoto, Ueno et 
al. 2003). The presence of the capsule slows the clearing of this bacterium from the blood stream, 
and also causes the strains to be more invasive in subcutaneous tissue infections (Yoshida, Ogawa 
et al. 1985).  Several genes have been shown to be responsible for capsule production in V. 
vulnificus, and mutations in these genes have eliminated capsule production and caused the 
resultant mutants to appear translucent. Examples include epimerase genes such as wcvA and wbpP  
(Zuppardo and Siebeling 1998, Smith and Siebeling 2003, Park, Lee et al. 2006), 
glycosyltransferase genes, such as  wcvF and wcvI (Smith and Siebeling 2003), and a 
polysaccharide polymerase gene, such as wzy (Nakhamchik, Wilde et al. 2007). A group I CPS 
operon composed of the highly conserved wza-wzb-wzc genes, an operon polarity suppressor (ops) 
element, and other less-conserved capsule biosynthesis genes were also identified as being 
involved in capsule production (Wright, Powell et al. 2001). Mutations in wza, which is a 
polysaccharide transporter, resulted in colonies that could not produce capsule and remained phase 
locked in the translucent state (Wright, Powell et al. 2001, Chatzidaki-Livanis, Jones et al. 2006). 
It was also demonstrated that deletion of the wzb gene (a tyrosine phosphatase required in capsular 
polysaccharide chain elongation), caused by homologous recombination between flanking direct 
repeats also resulted in phase locked translucent colonies (Chatzidaki-Livanis, Jones et al. 2006). 
Reverse transcriptase PCR data has shown that reduced transcription of the wzb gene was 
associated with colonies of an intermediate phenotype (Rosche, Smith et al. 2006). In 2011, our 
lab demonstrated that the opaque to translucent phase switch of V. vulnificus growing in LB2 
supplemented with 1 mM Ca2+, sometimes corresponded with deletions in the wzb gene (Garrison-






A number of regulators have also been demonstrated to be involved in the process of V. 
vulnificus phase variation. Deletions in rseB, a periplasmic negative regulator of alternative sigma 
factor E (involved in heat stress response) have been associated with reversible phase variation in 
V. vulnificus (Brown and Gulig 2009).  It has been reported in V. vulnificus that phase variation is 
influenced by rpoS, which is a sigma factor involved in bacterial stress response (Hilton, Rosche 
et al. 2006, Gauthier, Jones et al. 2010). Deletions in gacA, which is a response regulator involved 
in a two-component signal transduction system, significantly decreased phase variation of the 
opaque to the translucent phenotype, which the authors speculated was due to reduction of rpoS 
mRNA in the gacA mutant background (Gauthier, Jones et al. 2010), however this study did not 
directly study the role of rpoS in V. vulnificus phase variation.  
In V. vulnificus, it has been reported that environmental parameters such as temperature 
and aeration influence capsular polysaccharide phase variation but quorum sensing, biofilm 
formation, choice of media and oxidative stress do not (Hilton, Rosche et al. 2006). In addition, 
previous studies in our lab have established a role for the divalent cation, calcium (Ca2+) in 
modulating CPS and EPS phase variation in V. vulnificus (Garrison-Schilling, Grau et al. 2011).  
The rugose phenotype may aid in survival of bacteria under adverse environmental 
conditions (Costerton, Stewart et al. 1999, Davey and O'Toole G 2000, Grau, Henk et al. 2005).  
V. vulnificus rugose cells have been shown to have increased resistance to serum killing (Grau, 
Henk et al. 2005), chlorine stress (Guo and Rowe-Magnus 2010), and they are also very adept at 
biofilm formation (Grau, Henk et al. 2005, Guo and Rowe-Magnus 2010). Biofilms are a 
congregation of bacteria that can form on biotic or abiotic surfaces and are enclosed in a hydrated 






of advantages to bacteria such as protection from biocides (Mah and O'Toole 2001), predation 
(Matz, McDougald et al. 2005), osmotic and oxidative stress (Wai, Mizunoe et al. 1998), and 
chlorine resistance (Yildiz and Schoolnik 1999), as well as providing increased access to nutrients 
(Donlan and Costerton 2002). In 2009, Srivastava et al. demonstrated in a laboratory setting that 
V. vulnificus existed primarily in the opaque phenotype in oysters while in seawater they existed 
predominantly in the rugose form (Srivastava, Tucker et al. 2009).  
A number of genes that affect the V. vulnificus rugose phenotype and biofilm formation 
have been studied. It was demonstrated that the presence of capsule inhibits biofilm formation 
(Joseph and Wright 2004). The inhibitory effect of capsule on V. vulnificus biofilm formation was 
confirmed when a mutant in wbpP, an epimerase participating in capsule production, formed 
significantly more biofilm than the wild type (Lee, Kim et al. 2013). Surface structures such as pili 
and flagella also play a role in biofilm formation as inactivation of both pilA, a type IV pilus gene 
and flaE, a flagellar hook gene reduced the biofilm forming ability of V. vulnificus (Lee, Rho et al. 
2004). In silico analysis of two V. vulnificus strains have identified three EPS loci participating in 
EPS production (Kim, Park et al. 2009). EPS-I has genes homologous to the symbiosis related 
polysaccharide (syp) locus in V. fischeri, which was later designated as ‘rbd’ - regulation of biofilm 
development - and plays a role in biofilm enhancement and aggregate formation but not in stress 
resistance, and is not absolutely necessary for biofilm formation (Guo, 2011). EPS-II is a nine-
gene cluster, initially called wcrA-K, but then renamed brpA-K (for biofilm and rugose 
polysaccharide), which encodes proteins involved in EPS biosynthesis and transport (Grau, Henk 
et al. 2008, Guo and Rowe-Magnus 2010). EPS-III shows homology to a tentative cluster in V. 






clusters confirmed their involvement in V. vulnificus biofilm formation (Kim, Park et al. 2009, 
Guo and Rowe-Magnus 2010, Garrison-Schilling, Kaluskar et al. 2014).  
An intracellular signaling molecule, bis-(3’,-5’)-cyclic-di-GMP (c-di-GMP), has also been 
shown to influence biofilm formation in V. vulnificus (Nakhamchik, Wilde et al. 2008). For 
example, it has also been shown that transcription of brpA-K and their two cognate regulatory 
genes, brpR and brpT, is controlled by c-di-GMP (Guo and Rowe-Magnus, 2010). On the other 
hand, the rbd locus does not appear to be regulated by c-di-GMP (Guo and Rowe-Magnus, 2011). 
A number of regulators also have been identified to influence the V. vulnificus biofilm 
phenotype. A nitrogen regulator, ntrC, affects biofilm formation by acting as a transcriptional 
activator of gmhD, an epimerase that plays a role in exopolysaccharide synthesis (Kim, Lee et al. 
2007). In addition, a carbon storage regulator, csrA, has been shown to negatively regulate biofilm 
formation (Jones, Warner et al. 2008).  Furthermore, a quorum sensing regulator, smcR has been 
shown to play a role in biofilm dissociation by upregulating the expression of  VvpE, an elastolytic 
protease that has been shown to dissolve biofilms (Kim, Park et al. 2013). 
Only a few studies have elucidated specific environmental factors that affect biofilm 
formation in V. vulnificus.  Biofilm formation and EPS production was increased in a medium 
containing tricarboxylic acid intermediates as a carbon source and decreased in high nitrogen 
conditions. These processes were controlled by NtrC (Kim, Park et al. 2009). A previous study 
from our lab has demonstrated that supplementation of the medium with Ca2+ at millimolar levels 
can enhance biofilm formation in V. vulnificus (Garrison-Schilling, Grau et al. 2011).  
Our overall aim in this dissertation work was to gain a deeper insight into the process of   






of various divalent cations that could induce phase variation in V. vulnificus, with an emphasis on 
the role of manganese on phase variation and biofilm formation. Also, in chapter 2, we have 
determined potential genetic components that are involved in V. vulnificus phase variation and 
have discussed the potential role of the stationary phase regulator, rpoS in the same. In chapter 3, 
we have compared the proteomic profiles of the opaque and the rugose phase variants in V. 
vulnificus and have further tried to characterize the role of a MalE, a sugar binding periplasmic 
protein, in V. vulnificus rugosity. In chapter 4, we have studied the distribution of EPS producing 



























Vibrio vulnificus is a Gram-negative halophile inhabiting estuaries and marine 
environments where it exists in the water column, sediments and also in the guts of filter feeders 
like shrimp and oysters. Consumption of raw seafood by individuals suffering from health 
conditions like diabetes, liver cirrhosis and hemochromatosis can cause gastroenteritis and 
septicemia, whereas exposure of skin lesions to seafood or seawater can cause wound infections 
(Oliver 2013). Pathogenesis is caused by capsule producing, opaque (O) strains (Amako, Okada 
et al. 1984, Yoshida, Ogawa et al. 1985, Simpson, White et al. 1987). Under lab conditions, non-
pathogenic translucent (T) colonies arise from pathogenic encapsulated strains by reduction or 
total loss of capsular material (Yoshida, Ogawa et al. 1985, Simpson, White et al. 1987, Wright, 
Simpson et al. 1990, Grau, Henk et al. 2005). Likewise, the translucent strains can switch to the 
opaque phenotype by production of capsular polysaccharide (CPS) (Grau, Henk et al. 2005). 
Additionally, production of exopolysaccharide (EPS) gives rise to the rugose (R) phenotype, which 
appears dry and wrinkled on agar surface and has the ability to form copious biofilms (Grau, Henk 
et al. 2005). This spontaneous change from one phenotype to another is referred to as phase 
variation.  
Phase variation is defined as a reversible change in phenotype accompanied by genetic or 
epigenetic changes which can increase bacterial fitness, aid in survival and provide protection 
against host defense (Wisniewski-Dyé and Vial 2008). Surface structures like proteins, pili, 






Woude and Baumler 2004). Various genetic mechanisms like site-specific recombination, 
homologous recombination, insertions, deletions, slipped strand mispairing and epigenetic 
mechanisms like methylation have been identified to lie at the basis of phase variation in different 
organisms (van der Woude and Baumler 2004, Wisniewski-Dyé and Vial 2008). A number of 
environmental factors causing phase variation have been documented as well. Pili in N. 
gonorrhoeae undergo increased phase variation due to iron starvation (Serkin and Seifert 2000). 
Temperature, pH, carbon source and amino acid concentration affect fimbrial phase variation in 
Escherichia coli and Salmonella typhimurium (van der Woude and Baumler 2004).   
In V. vulnificus, one genetic mechanism has been identified to cause the irreversible switch 
from the opaque to the translucent phenotype. This mechanism involves deletions of wzb (a 
tyrosine phosphatase gene participating in capsule biosynthesis), which are caused by 
recombination between flanking direct repeats (Chatzidaki-Livanis, Jones et al. 2006, Garrison-
Schilling, Grau et al. 2011). The switch from O and T to the R phenotype has been shown to be 
accompanied by increased transcription of brp (formerly wcr) genes (Grau, Henk et al. 2008, Guo 
and Rowe-Magnus 2010). Deletions in rseB, a periplasmic negative regulator of alternative sigma 
factor E caused increased polysaccharide phase variation in V. vulnificus (Brown and Gulig 2009). 
It has been reported in V. vulnificus that phase variation appears to be a stationary phase 
phenomenon as it was speculated that decreased mRNA levels of rpoS (stationary phase sigma 
factor) in a gacA (response regulator) mutant was responsible for reduced phase variation in V. 
vulnificus strain CMCP6 (Gauthier, Jones et al. 2010); however, this study did not directly study 






In V. vulnificus, it was reported that temperature and aeration influence phase variation but 
quorum sensing, biofilm formation, choice of media and oxidative stress do not (Hilton, Rosche 
et al. 2006). It has also been reported that tricarboxylic acid intermediates enhance biofilm 
formation but higher nitrogen levels inhibit the same (Kim, Park et al. 2009). Previous studies in 
our lab established a role for calcium (Ca2+) in enhancing the propensity of opaque strains to switch 
to translucent and rugose variants. The calcium-induced opaque to translucent switch was 
sometimes associated with deletions in the wzb gene. Calcium was also found to increase biofilm 
mass; therefore, this cation appears to serve a dual role in persistence of V. vulnificus in the 
environment (Garrison-Schilling, Grau et al. 2011).   
 It was proposed that the phase switching response of V. vulnificus to Ca2+ may have 
evolved as an adaptive consequence of temporal fluctuations of this cation in estuaries (Garrison-
Schilling, Grau et al. 2011).  As the estuarine concentration of other cations such as barium (Ba2+), 
manganese (Mn2+) and strontium (Sr2+) have also been reported to vary (Elsdon and Gillanders 
2006), we tested here whether any of these could similarly affect exopolysaccharide phase 
variation in V. vulnificus.  We found that Mn2+ also dramatically increases the frequency of phase 
switching.  While some strains switched predominantly to the same variant type in both Ca2+ and 
Mn2+, the phenotypic effects of Ca2+ and Mn2+ on other strains were different. We also have 
attempted to study the role of wzb gene deletions and the rpoS gene in manganese-induced phase 










Identification of manganese as an additional cation that promotes phase variation in 
V. vulnificus.  Previously, we found that supplementation of LB2 broth with 1 mM Ca2+ (LB2+Ca) 
caused a significant increase in switching of opaque strains to translucent and rugose isolates 
(Garrison-Schilling, Grau et al. 2011).  In a similar manner, here we assessed the addition to LB2 
of 1 mM Ba2+ (LB2+Ba), 1 mM Mn2+ (LB2+Mn) or 1 mM Sr2+ (LB2+Sr) on phase variation of 
opaque strain 1003(O).  As previously described, our switching assays involved daily passaging 
of strains in the medium of choice with plating for individual colonies following a certain number 
of passages (e.g., 5) and subsequent enumeration and scoring of colonial phenotypes (Garrison-
Schilling, Grau et al. 2011).   
After 5 passages in LB2+Mn, 70.4 ± 25.9 % of strain 1003(O) colonies had switched to 
the translucent phase while 10.5 ± 9.3 % of the colonies remained opaque, 0.7 ± 0.4 % were 
sectored and 18.4 ± 16.9 % were of an indeterminant phenotype.  These results contrasted 
substantially with LB2 alone, where only 0.1 ± 0.1 % of colonies had switched to the translucent 
phase after 5 passages with 99.9 ± 0.1 % remaining opaque.  Using a linear mixed models ANOVA 
analysis and a significance cutoff of P < 0.05, the percentage of colonies that switched to 
translucent in LB2+Mn was significantly greater (P = 0.0002) than the percent that switched to 
this phenotype in LB2 alone.  The percentage of translucents in LB2+Mn was comparable and not 
significantly different (P = 0.1360) from the percent seen in LB2+Ca (44.6 ± 21.1 %).   In contrast 
to the results for LB2+Mn, no switching of 1003(O) was observed after 5 passages in LB2+Ba, 
and switching in LB2+Sr occurred predominantly to the rugose phenotype at passage 5 (7.5 ± 13.0 







Figure 2.1: Evidence that Mn2+ promotes exopolysaccharide phase variation in V. vulnificus. 
Switching assays were performed for 5 passages for strain 1003(O) in LB2, LB2+Ba, LB2+Ca, 
LB2+Mn, and LB2+Sr.  Dilutions and platings of the initial overnight (ON) culture and following 
5 passages were conducted in order to count and score colony phenotypes. The proportion of 
opaque (O), translucent (T) and rugose (R) colonies were calculated for 3 independent experiments 
and the means ± SD are presented.    
 
During the course of these switching assays we noticed that strain 1003(O) grew at a visibly 
slower rate in LB2+Mn than LB2 alone.  This observation was confirmed by growth curves in the 
two media (Figure 2.2), which showed a significant difference in mean OD600 at all time-points 
tested for 1003(O) (max P = 0.0029).  We wondered whether the increased appearance of 
translucent isolates in LB2+Mn was related in any way to the slower growth rate of 1003(O) in 










Figure 2.2: Growth curves of strain 1003(O) and a translucent derivative in LB2, LB2+0.2Mn, 
LB2+Mn.  At least 5 independent replicates were performed and OD600 values were averaged at 
each time point.  Error bars indicate SD.  
 
To address this possibility, we sought to compare rates of phase variation in LB2+Mn 
versus LB2 containing a lower concentration of Mn2+ that would not slow down the growth of 
strain 1003(O).  Previous results with Streptococcus mutans showed growth inhibition of that 
organism in Mn2+ concentrations greater than 0.2 mM (Arirachakaran, Luengpailin et al. 2007), 
prompting us to test LB2 supplemented with 0.2 mM Mn2+ (LB2+0.2Mn) as the additional 
medium.  In switching assays of strain 1003(O) in LB2, LB2+0.2Mn and LB2+Mn,  it was found 
that, after 5 passages in LB2+0.2Mn,  84.9 ± 14.2 % of colonies had switched to translucent and 








Figure 2.3: Comparable increases in phase variation in the presence of 1 mM and 0.2 mM Mn2+. 
Switching assays for strain 1003(O) were conducted in LB2, LB2+0.2Mn, and LB2+Mn for 5 
passages.  Dilutions and platings were performed as described in Figure. 2.1. The proportion of 
each phenotype was calculated for 3 independent experiments and the means ± SD are presented.    
 
This percentage of translucent and rugose colonies was significantly different (P < 0.0001) 
from that seen in LB2 where 98.6 % ± 0.6 % of colonies remained opaque after 5 passages, but it 
was not statistically different from LB2+Mn (P = 0.2466), where after 5 passages 97.5 ± 2.2 % 
and  0.3 ± 0.6 % colonies had switched to translucent and rugose, respectively.   
An examination of growth curves (Figure 2.2) for strain 1003(O) in LB2+0.2Mn versus 
LB2 revealed no significant differences for the majority of time points (data not shown).  Since 
the percent of translucent and rugose colonies obtained in LB2+0.2Mn and LB2+Mn was 






unrelated to the slow growth observed in this medium. Though slower growth in 1 mM Mn2+ could 
be due to the toxic effects of this divalent cation on V.vulnificus, our data suggests that 0.2 mM 
Mn2+ seems to be sufficient for phase variation. An additional comparison of growth curves 
(Figure 2.2) in LB2+0.2Mn for 1003(O) and a translucent derivative (i.e., strain 1003[T], isolated 
in switching assays in LB2+Mn) indicated that, for the majority of time points, either 1003(O) 
grew significantly better than 1003(T) or there was no significant difference between them (data 
not shown).  No significant differences were also seen at the majority of time points for these two 
strains in LB2+Mn (data not shown). These latter observations suggest that the increased 
appearance of translucent colonies following growth of 1003(O) in media with elevated [Mn2+] 
results mainly from an increased propensity for phase variation rather than a growth advantage for 
the resulting translucent derivatives.    
Comparison of phenotypic effects for increased [Ca2+] versus [Mn2+] among V. 
vulnificus strains.  Increased Ca2+ was shown to promote switching of some V. vulnificus opaque 
strains to predominantly the translucent phenotype (e.g., strain 1003[O]) while others switched to 
the rugose phase (Garrison-Schilling, Grau et al. 2011).  Here, we found that Mn2+ also induced 
switching of 1003(O) to mainly the translucent phenotype (Figures 2.1 and 2.3).  To further 
compare the effects of equimolar increases in Mn2+ and Ca2+, we subjected additional V. vulnificus 
opaque strains to switching assays and representative results are presented here. Opaque strain 
MLT124, which previously switched predominantly to rugose in LB2+Ca, showed the same 
expected pattern here in this medium (Figure 2.4).  MLT124 also switched mainly to rugose in 
LB2+Mn, although the percent switching in LB2+Mn relative to LB2 alone was not significant by 






had become rugose in LB2+Mn as compared to only 2.5 ± 4.3 % in LB2 (Figure 2.4), and the 
percent switching in these two media was considered to be significantly different (P = 0.0242).  
 
 
Figure 2.4: Enhanced phase switching from opaque to predominantly rugose for strain MLT124 in 
the presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn and LB2+Ca 
for 15 passages.  Dilutions and platings were done on the ON culture and after 5, 10 and 15 
passages.  The proportion of each phenotype was calculated for 3 independent experiments and 
the means ± SD are presented.    
 
It was previously demonstrated that opaque strain C7184 predominantly switched to 
translucent colonies in LB2+Ca at the end of 10 passages. The presence of manganese also induced 
a switch from opaque to 44.0 ± 27.3 % T phenotype after 5 passages, which was significant  
(P<0.0001) in comparison to LB2 where colonies remained nearly 99 % opaque at  this point 








Figure 2.5: Enhanced phase switching from opaque to predominantly translucent for strain C7184 
in the presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn and 
LB2+Ca for 5 passages. Dilutions and platings were performed as described in Figure 2.1.  The 
proportion of each phenotype was calculated for 6 independent experiments and the means ± SD 
are presented.  
 
As previously observed in LB2+Ca, opaque strain YJ016 switched to predominantly 
translucent colonies in LB2+Mn. Though switching to 6.3 ± 9.0 %, 20.1 ± 15.2 % and 24.3 ± 8.6 
% translucent colonies was observed after passages 5, 10 and 15, respectively, in 1 mM Mn2+ 
(Figure 2.6), this switching was not deemed statistically significant according to our analysis 
despite the fact that colonies in LB2 remained more than 96.4 % opaque at all passages. 
Contrasting phenotypic effects for Ca2+ and Mn2+ could also be demonstrated. In LB+Ca, 
opaque strain MLT136 switched predominantly to rugose previously and here (Figure 2.7), while 
66.5 ± 7.8 % of MLT136 colonies instead switched to translucent after 5 passages in LB2+Mn 













Figure 2.6: Phase switching from opaque to predominantly translucent for strain YJ016 in the 
presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn and LB2+Ca 
for 15 passages.  Dilutions and platings were done on the ON culture and after 5, 10 and 15 
passages.  The proportion of each phenotype was calculated for 3 independent experiments and 
the means ± SD are presented.    
 
 
Figure 2.7: Enhanced phase switching from opaque to predominantly translucent for strain 
MLT136 in the presence of increased [Mn2+].  Switching assays were performed in LB2, LB2+Mn 
and LB2+Ca for 5 passages.  Dilutions and platings were performed as described in Figure 2.1.  
The proportion of each phenotype was calculated for 3 independent experiments and the means ± 

























It was previously observed that opaque strain CPSed5 switched predominantly to rugose 
colonies in LB2+Ca and the same pattern was observed here in the same medium. However it 
switched  largely to translucent colonies at passages 10 (12.7 ± 14.2 %) and 15 (64.5 ± 33.1 %) in 
media supplemented with manganese. Compared to the LB2 control, this effect was significant at 
passage 15 only (P= 0.0117) (Figure 2.8).  
 
 
Figure 2.8: Enhanced phase switching from opaque to predominantly translucent for strain CPSed5 
in the presence of increased [Mn2+]. Switching assays were performed in LB2, LB2+Mn and 
LB2+Ca for 15 passages.  Dilutions and platings were done on the ON culture and after 5, 10 and 
15 passages. The proportion of each phenotype was calculated for 3 independent experiments and 
the means ± SD are presented.    
 
As with strain 1003(O), the other strains examined here grew noticeably slower in LB2 + 
Mn.  For example, both MLT124 and MLT136 grew significantly slower (max P< 0.0001) 

























rugose isolate of MLT124 (i.e., MLT124[R]) grew significantly better (max P = 0.0004 at time 4 
h and beyond) than MLT124 in LB2+Mn (Figure 2.9a), while there was no significant difference 
(data not shown) at the majority of time points between MLT136 and its translucent derivative, 
MLT136(T), in that same medium (Figure 2.9b). Taken together, our results here support the 
notion that Mn2+ increases the frequency of phase switching of opaque V. vulnificus strains to the 
translucent or rugose states, though a selective growth advantage for resulting phase variants of 
certain strains may also be a contributing factor in their appearance. 
 
 
Figure 2.9: Growth curves of strains (a) MLT124 and a rugose derivative, (b) MLT136 and a 
translucent derivative in LB2 and LB2+Mn.  At least 5 independent replicates were performed and 









(Figure 2.9 continued) 
 
Genetic basis of opaque to translucent switch involves genetic changes in the wzb gene. 
Deletions in the wzb gene, which functions as a tyrosine phosphatase during capsule biosynthesis, 
have been demonstrated to be involved in the irreversible switch from opaque to translucent 
phenotypes in V. vulnificus (Chatzidaki-Livanis, Jones et al. 2006). It was also shown by Garrison 
et al. that deletions in the wzb gene are associated with phase switching of opaque to translucent 
phenotypes observed upon calcium supplementation (Garrison-Schilling, 2011). To determine if 
deletions in wzb are also associated with Mn2+ induced phase switching, PCR’s were performed 
using wza-For and wzc-Rev primers as mentioned (Garrison-Schilling, 2011). Genomic DNA 
from 13 T phase variants of different strains obtained during switching assays in LB2+0.2 Mn and 







One of the phase variants amplified a 0.85 kb band, which indicated a deletion event, and two of 
the remaining strains did not amplify any bands indicating complete deletion of wzb or mutations 
in the primer binding regions. Additionally, one of the phase variants amplified a 3.0 kb band 
indicating a duplication or an insertion event (Table 2.1).  
 
Table 2.1: wzb gene region PCR band sizes in translucent variants obtained during switching 
assays in LB2 supplemented with manganese. 
 
Strain    wzb band size (kb) 
1003-T8  1.40  
1003-T9  1.40 
1003-T10  1.40 
1003-T11  1.40 
1003-T12  1.40 
1003-T13  1.40 
1003-T14  1.40 
1003T-15  0.85 
MLT124-T6  1.40 
MLT124-T7  1.40 
MLT136-T7  3.00 
MLT136-T8  No band  







Role of rpoS in V. vulnificus phase variation. A study determining the factors influencing 
capsular polysaccharide phase variation in V. vulnificus suggested that rpoS, which encodes a 
sigma factor important for the stationary phase stress response, may be involved (Hilton, 2006). 
Also, Gauthier et al. (Gauthier, 2010) speculated that reduction in the levels of rpoS mRNA 
transcript in a gacA response regulator mutant strain results in a reduction in phase variation of V. 
vulnificus. Our switching assay procedure for determination of phase variation involves incubating 
passaged cultures for 18-24 hours before plating. Since V. vulnificus reaches stationary phase by 
approximately 6 hours (unpublished data), we hypothesized that rpoS may participate in Ca2+- and 
Mn2+-induced phase variation in V. vulnificus.  Previous studies in our lab indicated that, while 
strain C7184 readily underwent phase variation in the presence of calcium, its rpoS mutant 
derivative AH1 (Hulsmann, Rosche et al. 2003) did not. Here we wanted to test whether rpoS was 
involved in Mn2+-induced phase variation as well. Switching assays performed on C7184 and AH1 
in the presence of LB2 and LB2+Mn indicated that both showed an ability to switch to the 
translucent phase though the mutant appeared to do so at a reduced frequency (Figure 2.10a, b).  
We attempted to determine if complementation of rpoS in trans in strain AH1 would restore 
its phase variation capability back to the level seen for C7184.  Plasmid pVV70, which contains 
the rpoS gene of C7184 cloned onto vector pBBRAD2kan, was introduced into strain AH1 to 
create AH1-C.  Similarly, the empty vector pBBRAD2kan was introduced to create strain AH1/ 
pBBRAD2kan.  
Switching assays were then performed on strains AH1-C and pBBRBAD2Kan/AH1 in the 






arabinose to the medium. Unexpectedly, the AH1-C did not show increased phase variation 




Figure 2.10: Role of rpoS in Ca2+ and Mn2+ induced V. vulnificus phase variation. Switching assays 
were performed on (a) C7184, (b) AH1, (c) AH1-C, (d) AH1/pBBRBAD2Kan in LB2, LB2+Ca, 
LB2+Mn supplemented with 0.2 % arabinose and antibiotics as required. Switching assays were 
carried out for a total of 15 passages. Phase variation was assayed by dilution and plating of the 
















































colony phenotype  








(Figure 2.10 continued) 
   
Prior to switching assays, growth curves were performed on C7184, AH1, AH1-C and 
AH1/ pBBRAD2kan in LB2, LB2+Ca and LB2+Mn supplemented with 0.2 % arabinose and the 
respective antibiotics. The growth of all of these strains was very similar in LB2 and LB2+Ca. 

















































Figure 2.11: Growth curves on C7184, AH1, AH1-C and AH1/pBBRBAD2Kan in LB2, LB2+Ca, 
LB2+Mn supplemented with the appropriate antibiotics and 0.2 % arabinose. At least 5 
independent replicates were performed and OD600 values were averaged at each time point. Error 
bars indicate SD.   
 
These results could mean that there is a potential problem with rpoS expression from the 
complementation system employed.  A future experiment integrating rpoS under the control of its 
own promoter into the AH1 chromosome before performing switching assays on this strain should 
be conducted.  
Assessment of the ability of manganese to enhance biofilm formation in V. vulnificus. 
Previously, we observed that an elevated [Ca2+] concentration promoted both phase variation and 
biofilm production in V. vulnificus (Garrison-Schilling, Grau et al. 2011).  The potential effect of 
increased [Mn2+] on biofilm formation of representative V. vulnificus strains was assessed here 






























rugose strains KG3(R) & BG(R) biofilms from cultures grown in LB2, LB2+Ca, and LB2+Mn 
media.  Supplementation of LB2 with Mn2+ increased biofilm formation of KG3(R) by 7.2 fold 
relative to the LB2 control, an effect that appeared similar to the 9.3-fold enhancement observed 
for LB+Ca (Table 2.2). The increased biofilm mass seen here in LB2+Mn and LB2+Ca compared 
to LB2 alone were both deemed significant (both P < 0.0001).  Despite the significant increase in 
biofilm formation for strain KG3(R) in LB2+Mn, this enhancement was statistically lower (P = 
0.0095) than the increase seen for KG3(R) in LB2+Ca (Table 2.2).   
Enhanced biofilm production in the presence of increased [Mn2+] was also qualitatively 
observed for strain BG(R) where a 3.7 fold increase was observed in biofilm formation compared 
to LB2; however, this increase was not deemed to be statistically significant (P=0.1682). As 
expected, strain BG(R) showed a significant enhancement of biofilm formation in the presence of 
LB2+Ca compared to LB2 (P<0.0001) (Table 2.2).   
 
Table 2.2: Mn2+ enhances biofilm formation in V. vulnificus. Biofilm assays were performed on 
strains BG(R) and KG3(R) by measuring absorbance of extracted CV at OD570 and multiplying by 
the dilution factor, if necessary. Data shown here are means and standard deviations from three 
trials with at least 5 experiments conducted in each trial. Ratios were calculated by dividing mean 
OD570 value in a particular media by mean OD570 value in LB2. a Ratio for biofilm formation in 
LB2+Ca. b Ratio for biofilm formation in LB2+Mn.  
 
 Biofilm formation (OD570 of CV) 
   Strain       LB2       LB2+Ca         LB2+Mn   Ratioa    Ratiob 
                                        ±SD       ±SD         ±SD 
 BG(R) 0.15 ± 0.05 2.64 ± 0.96      0.57 ±0.53   17.20 3.70 








Here we have demonstrated that phase variation of either CPS or EPS production in V. 
vulnificus is responsive to an additional environmental signal, which is manganese.  We previously 
postulated that phase switching of opaque V. vulnificus variants to either translucent or rugose may 
be an adaptive consequence of the temporal variability in [Ca2+] that has been documented in 
estuaries (Garrison-Schilling, Grau et al. 2011). As estuarine Mn2+ concentrations are also known 
to vary, a similar argument can be made for the observed response to this cation.  Unlike Ca2+, 
however, Mn2+ concentrations measured in estuarine waters were well below the millimolar range 
that we used in our studies (Elsdon and Gillanders 2006, Azlisham, Vedamanikam et al. 2009); 
nevertheless, it is noteworthy that temporal  fluctuations of Mn2+  in the millimolar range has been 
documented in both sediment and oyster samples from coastal areas (Azlisham, Vedamanikam et 
al. 2009).     
Ca2+ promotes biofilm formation in V. vulnificus (Kierek and Watnick 2003a, Garrison-
Schilling, Grau et al. 2011).  Though, the molecular mechanism of biofilm formation by Ca2+ has 
not yet been elucidated, Ca2+ has been proposed to act as a sensory ion which regulates gene 
expression of biofilm associated components in some organisms, while in others a structural role 
for Ca2+ in the biofilm matrix has been proposed (Patrauchan, Sarkisova et al. 2005). Kierek and 
Watnick (Kierek and Watnick, 2003a) provided compelling evidence that Ca2+ is an integral 
component of one type of biofilm produced by Vibrio cholerae, perhaps forming intercellular salt 
bridges between cell-associated components. An analogous role for Ca2+ in biofilm formation of 
other Vibrio spp., including V. vulnificus, was also postulated (Kierek and Watnick 2003a, 






Mn2+ is also capable of serving a similar structural role in biofilm formation in bacteria.  In S. 
mutans, Mn2+ promoted formation of non-sucrose biofilms, which showed greater biomass, 
substratum occupation, thickness, and roughness than biofilms formed in the absence of Mn2+ 
(Arirachakaran, Luengpailin et al. 2007). It was also reported that dental plaques had orders of 
magnitude greater concentrations of Mn2+ than that found in saliva (Arirachakaran, Luengpailin et 
al. 2007).  Kierek and Watnick (Kierek and Watnick 2003a) also noted that while pre-formed Ca2+-
dependent biofilms of V. cholerae rapidly dissolved in media lacking Ca2+, this dissolution was 
slowed when the media was amended with Mn2+.  Taken together with our results here, it is 
possible that Mn2+ can play a role in biofilm structuring, although alternative or additional roles 
such as affecting relevant gene expression can also be imagined.          
There are now several examples of Vibrio spp. responding to cations normally present in 
their marine environments.  In addition to the effects of Mn2+ and Ca2+ on phase variation in V. 
vulnificus, magnesium was found to enhance flagellation in V. fisheri (O'Shea, Deloney-Marino et 
al. 2005).  Calcium and iron (Fe2+) also affected swarming and type III secretion in V. 
parahaemolyticus (Gode-Potratz, Chodur et al. 2010).  In the latter case, regulons of genes 
responsive to Ca2+ and Fe2+ were revealed and a transcriptional regulator was identified which 
promotes Ca2+-regulated gene expression.     
The underlying mechanism(s) of how Mn2+ promotes phase variation in V. vulnificus 
remains to be fully elucidated. Manganese homeostasis in bacteria is maintained by regulated 
transport systems, and Mn2+ metalloenzymes that participate in numerous metabolic pathways 
(e.g., glycolysis, gluconeogenesis, amino acid metabolism), as well as other important functions, 






Manganese-regulated transcriptional control has also been documented, perhaps most notably by 
the Fur metallorepressor protein, which binds Fe2+ or Mn2+ to regulate numerous target genes in a 
variety of Gram-negative bacteria, including Vibrio spp. (Troxell and Hassan 2013). Our data from 
the wzb gene deletions indicate that even though this mechanism may be one of the means of phase 
variation there does exist at least one other mechanism which brings about the switch from O to T 
phenotype since some of the T isolates characterized had no apparent deletion of this genetic 
region. Additionally, our results showing the rpoS mutant undergoing phase variation in the 
presence of Mn2+ at an apparent reduced frequency compared to the wild type parent implies a role 
for the rpoS gene in V. vulnificus but this needs further experimentation. In Pseudoalteromonas 
sp. PCL1171, phase variation between the opaque and translucent phenotypes is dependent on 
spontaneous mutations in the regulatory genes, gacA & gacS. Constitutive expression of rpoS in 
this organism increases the frequency at which gac mutants appear by 10 fold (van den Broek, 
Chin et al. 2005). Elucidation of the pathway(s) by which Mn2+ (and Ca2+) promotes colonial phase 
variation in V. vulnificus will provide further insight into how this marine inhabitant and human 
pathogen persists and responds to changing environmental conditions.    
MATERIALS AND METHODS 
Strains and growth conditions: V. vulnificus strains were stored at -70°C in heart infusion 
broth, (Difco) supplemented to a total of 2% NaCl (HI) with 15 % glycerol added.  Frozen stocks 
were streaked on HI agar supplemented with 18g/L non- granulated agar (Difco) for single colony 
isolation. Plates were incubated at 30°C overnight (ON) for 16-24 hours and broth cultures were 
grown at 30°C ON for 16-24 hours with shaking at 200 rpm. E. coli strains were stored at -70°C 






LB agar supplemented with 15 g/L granulated agar (Difco) for single colony isolation. Plates were 
incubated at 37°C ON for 16-24 hours and broth cultures were grown at 37°C and 250 rpm ON 
for 16-24 hours. V. vulnificus switching assays and growth curves were carried out in LB2 (LB 
broth supplemented to a total of 2 % NaCl), LB2+Ba (LB2 supplemented with 1 mM BaCl2.2H2O), 
LB2+Ca (LB2 supplemented with 1 mM CaCl2.2H2O), LB2+0.2Mn (LB2 supplemented with 0.2 
mM MnCl2.6H2O), LB2+Mn (LB2 supplemented with 1 mM MnCl2.6H2O) and LB2+Sr (LB2 
supplemented with 1 mM SrCl2.6H2O). All experiments were conducted at least in triplicate in the 
above media at 30°C.  
Antibiotics (Sigma) were used as follows when needed: 50µg/ml ampicillin, 10µg/ml 
chloramphenicol and 150µg/ml kanamycin for V. vulnificus and 50µg/ml ampicillin, 2µg/ml 
chloramphenicol and 50µg/ml kanamycin for E. coli. Arabinose (Sigma) and IPTG (Sigma) were 
added to a final concentration of 0.2 % and 1 mM respectively as required. Strains and plasmids 
used in this study are listed in Tables 2.3 and 2.4 respectively.  
 
Table 2.3: Strains used in the study 
Strain    Description     Source or reference 
V. vulnificus 
1003(O)  formerly 1003; opaque wound isolate        (Martin and Siebeling 1991) 
from Louisiana   
1003(R)  spontaneous rugose phase variant of 1003(O)  This study 
from LB2+Mn 







(Table 2.3 continued) 
Strain    Description     Source or reference 
AH1   C7184 rpoS::pHA4; rpoS deficient   (Hulsmann, Rosche et al. 2003) 
AH1-C   AH1 containing rpoS on pBBRBAD2Kan, Kanr  This study 
AH1/pBBBRBAD2Kan AH1 containing pBBRBAD2Kan vector control   This study 
     transformed into AH1 
BG(R)   spontaneous rugose phase variant of 1003(O) (Grau, Henk et al. 2005) 
C7184                clinical opaque isolate     (Hulsmann, Rosche et al. 2003) 
CPSed5              sediment isolate         (Garrison-Schilling, Grau et al. 2011) 
KG3(R) spontaneous rugose phase variant of    (Garrison-Schilling, Kaluskar 2014) 
                                        YJ016       
MLT124(O)  oyster isolate, opaque        (Garrison-Schilling, Grau et al. 2011) 
MLT124(R)  spontaneous rugose from MLT124(O)   This study 
in LB2+Mn 
MLT124(T)  spontaneous translucent from MLT124(O)  This study  
   in LB2+Mn  
MLT136(O)  oyster isolate, opaque    (Grau, Henk et al. 2005) 
MLT136(R)  spontaneous rugose from MLT136(O)  
in LB2+Ca           (Garrison-Schilling, Kaluskar2014) 
MLT136(T)  spontaneous translucent from MLT136(O)       This study 
   in LB2+Mn 
YJ016   clinical isolate, opaque       (Chen, Wu et al. 2003)  
E.coli  
BRL2288  F- araD139 ∆(ara-leu)7679 ∆(Fabretti, Theilacker et al.)X74 
galU galK hsdR2 (rκ- mκ-) mcrB1 rpsL                 (Brasch, Pettis et al. 1993) 







(Table 2.3 continued) 
Strain    Description     Source or reference 
S17.1   thi pro hsdR hdsM+ recA                                    (Simon, Priefer et al. 1983)  
   RP4-2-Tc::Mu-Km-Tn7 
S17.1λpir  thi pro hsdR hdsM+                                              (Simon, Priefer et al. 1983) 
   recA RP4-2-Tc::Mu-Km-Tn7Λpir 
 
 
Table 2.4: Plasmids used in this study  
Plasmids   Description      Source 
Vectors 
pBBRBAD2      expression vector containing (Garrison-Schilling, Kaluskar 2014) 
pBAD promoter and araC gene, Chlr             
PBBRBAD2Kan expression vector containing pBAD    This study 
promoter, Kanr, Chls 
pSP72   cloning vector, Ampr     Promega 
Complementation clones  
pVV68  rpoS cloned into pSP72, Ampr   This study 








Switching assays: Single isolated colonies were first inoculated and grown in the 
respective medium overnight for 16-24 hours with shaking at 200 rpm. This culture was termed 
ON. ON cultures were subcultured 1:100 into 3 ml of the respective media being tested for a total 
of 15 days. Each subculture was termed a passage. Occurrence of phase variation was assayed by 
plating serial dilutions of each culture onto LB2 agar after ON and after every fifth passage. 
Phenotypes were scored as opaque (O)- capsule producing colonies, translucent (T)- colonies with 
no capsule production, rugose (R)- dry wrinkled colonies, sectored (S)- two phenotypes in one 
colony, and others (Ot)- colonies which exhibit any other phenotype not categorized above. 
Percent switching frequencies were calculated as the ratio of the number of colonies of a particular 
phenotype divided by the total number of colonies counted for that particular passage, which is 
then multiplied by 100 %.   
Growth curves: Single isolated colonies were first inoculated into the respective medium 
and cultures were grown overnight at 30°C for 16-24 hours with shaking at 200 rpm. The ONs 
were then diluted to an optical density (OD600) of 0.01 in 5 mL of the appropriate fresh medium 
and grown at 30°C and 200 rpm for 24 hours. OD600 was measured at 2,4,6,9 and 24 hours. The 
24-hour cultures were streaked on LB2 agar to determine if switching had occurred. 
Biofilm assays: Single isolated colonies were first inoculated into LB2, LB2+Mn and 
LB2+Ca overnight for 16-24 hours with shaking at 30°C and 200 rpm. These ON’s were then 
diluted to an OD600 of 0.02 into 1 ml of the media being tested. Cultures were incubated stationary 
at 30°C for 48 hours. The liquid cultures were then poured off and the aggregate ring formed was 
washed and stained with crystal violet. Biofilm formation was assessed by measuring OD570 of the 






Genetic analysis of the wzb gene: Genomic DNA was extracted from a total of 13 
translucent phase variants of 1003(O), MLT124 and MLT136 obtained during switching assays in 
LB2+0.2Mn and LB2+Mn using PureGene DNA isolation kit (Gentra). Polymerase chain 
reactions (PCRs) were then performed by using primers wza-For (5′-
GGTGCTCTACGCGTTAAAACG-3′) and wzc-Rev (5′-GAGTTATCAACGGAAGATCGG-3′) 
to amplify wzb and adjacent direct repeats as described previously (Garrison-Schilling, Grau et al. 
2011). Briefly, 100 ng of gDNA was added to a 25 µl reaction consisting of 2.5 µl 10X PCR buffer, 
10 % DMSO, 2 µl 10 mM total DNTPs, 1.5 µl 25 mM MgCl2, 1.25 µl each of  20 µM primers and 
0.2 µl of 5U/ µl Amplitaq.  PCR reactions were performed as follows: initial denaturation at 94°C 
for 1 min, followed by 35 cycles of 94°C for 1 min, 55 °C for 1 min, and 72 °C for 2 min, with a 
final extension of 72°C for 5 min. PCR products were then analyzed on a 0.7 % 1X TAE agarose 
gel after running for 45 min at 80 V.  
Generation of a complementation vector:  The 6,414-bp kanamycin-resistant, 
chloramphenicol-sensitive plasmid pBBRBAD2Kan was created by cloning the 840 bp SmaI  
kanamycin-resistance cassette from pACW29 (Wright, Powell et al. 2001) into the AclI and AseI 
sites of plasmid pBBRBAD2, which was blunt ended by filling in the 5′ overhangs using Klenow 
exo-. Primers RpoS up PstI (5′-AAAAACTGCAGTGCTAACTCGCCATGGGGAG-3′) and RpoS 
dn XbaI (5′-AAAAATCTAGAGCCAAGCGTTAGAAGCCCTA-3′) were used to amplify C7184 
gDNA to yield a 1,159 bp product, which was then digested with PstI and XbaI and cloned into 
corresponding sites on pSP72 to generate plasmid pVV68. This plasmid was maintained in E.coli 
strain S17.1λpir. The 1,139-bp PstI-XbaI fragment containing the rpoS gene was then lifted from 






was maintained in strain E.coli strain BRL2288. For conjugation, pVV70 was transformed into 
E.coli strain S17.1 and matings between S17.1 harboring the pVV70 and the V. vulnificus rpoS 
mutant AH1 were carried out on filter membranes and kanamycin- resistant transconjugants were 
subsequently selected. Complementation was induced by adding 0.2% arabinose to the media.  
Statistical analysis: Data generated in the switching assays, growth curve experiments and 
biofilm assays were analyzed using linear mixed models analysis of variance techniques (Littell, 
Milliken et al. 2006). SAS® 9.3 was used to perform all the analyses.  Analysis of each data set 
involved multifactor treatment structures with repeated measures design structures (Milliken and 
Johnson 1998). For growth curve experiments, the time intervals over which repeated measures 
were taken were unequally spaced, whereas for the switching assays they were equally spaced. In 
order to account for the potential correlation induced by the taking of repeated measurements, 
random effects or covariance structures were incorporated into the statistical models, as 
appropriate and as needed.  In order to maintain some level of control over the overall Type-I error 
rate in analyzing data for a particular experiment, overall tests were performed first. Follow-up 
tests for making specific comparisons were performed only when the overall tests indicated that 
differences existed among the various treatment levels.  For all statistical analyses performed, P < 
















COMPARATIVE PROTEOMIC ANALYSIS OF THE OPAQUE AND RUGOSE PHASE 
VARIANTS OF V. VULNIFICUS 
 
INTRODUCTION 
Vibrio vulnificus is a Gram-negative bacterium inhabiting saline environments around the 
world. It can exist in the sea or in estuarine locales where it is present in the water column, or in 
the sediment. It may be attached to plankton, or reside within filter feeding mollusks and other 
seafood. V. vulnificus is a human pathogen that is associated with the highest mortality rate among 
seafood-associated pathogens (Linkous and Oliver 1999, Strom and Paranjpye 2000). 
Consumption of raw seafood such as oysters, by people with underlying conditions such as 
hemochromatosis, diabetes and alcoholism may result in septicemia, whereas exposure of wounds 
to sea food drippings or contaminated water can cause wound infections which in severe cases 
may lead to amputation (Linkous and Oliver 1999, Strom and Paranjpye 2000, Oliver 2012).  
  Pathogenicity correlates with the production of capsular polysaccharide (CPS), which 
imparts a smooth, opaque (O) colonial phenotype (Amako, Okada et al. 1984, Yoshida, Ogawa et 
al. 1985, Simpson, White et al. 1987). Loss of CPS production imparts a smooth translucent (T) 
colonial phenotype, rendering the organism attenuated for virulence, or avirulent (Yoshida, Ogawa 
et al. 1985, Simpson, White et al. 1987, Zuppardo and Siebeling 1998). Furthermore, production 
of exopolysaccharide (EPS) by the O and T phenotypes results in a dry, wrinkled rugose (R) 
phenotype which has the ability to form copious biofilms (Grau, Henk et al. 2005, Grau, Henk et 
al. 2008). In nature, microorganisms are not typically present as dispersed single cells but are 
known to survive attached to surfaces as parts of biofilms, which are a conglomeration of microbes 






sequestering nutrients, provides resistance to toxins and protects cells from grazing and 
unfavorable conditions, thereby enhancing survival (Flemming and Wingender 2010). 
Interestingly in oysters, V. vulnificus has been shown to exist mostly in the opaque phenotype but 
in seawater it survives primarily as rugose (Srivastava, Tucker et al. 2009).  
In V. vulnificus several genes have been demonstrated to play a role in biofilm formation. 
Mutations in genes such as pilA, encoding pilus (Paranjpye and Strom 2005), flaE, encoding 
flagella, (Lee, Rho et al. 2004) and brp as well as rbd, functioning in polysaccharide biosynthesis 
and transport (Guo and Rowe-Magnus, 2010, Guo and Rowe- Magnus, 2011), have resulted in 
reduced biofilm formation. An intracellular signaling molecule, bis-(3’,-5’)-cyclic-di-GMP (c-di-
GMP), has also been reported to enhance V. vulnificus biofilm formation (Nakhamchik, Wilde et 
al. 2008). Transcriptional regulators including ntrC, a nitrogen regulator (Kim, Lee et al. 2007), 
csrA, a carbon storage regulator (Jones, Warner et al. 2008), smcR, a transcriptional regulator 
(Kim, Park et al. 2013), have also been shown to influence V. vulnificus biofilm formation.  
The purpose of this chapter’s research was to gain a deeper insight in the process of phase 
variation and rugose colony formation in V. vulnificus, by comparing the whole cell proteomic 
profile differences between the O and R phase variants using two-dimensional gel electrophoresis 
(2DGE) in conjunction with mass spectrometry (MS). Twenty eight proteins were found to be 
differentially expressed between the O and the R phenotypes, and the role of one protein, maltose 
binding periplasmic protein (MalE) was investigated further by transcriptional and mutational 








RESULTS AND DISCUSSION 
With the goal to better understand the processes of phase variation and rugose colony 
formation in V. vulnificus, we chose to compare the whole cell proteomic profiles of strain, YJ016 
to that of its isogenic derivative, rugose derivative KG3(R) (Garrison-Schilling, Kaluskar et al. 
2014).  Whole cell proteins were extracted from mid-log cultures by a combination of the TCA 
method and phenolic isolation. Our results indicated that there was a 3 to 9 fold increase in protein 
yield when a combination of TCA and phenol was used as opposed to TCA only. 2DGE separation 
of proteins on 4-7 pH Immobiline strips and 12.5% polyacrylamide gels (Figure 3.1a, b) and 
subsequent analysis of protein spots by PDQuest software identified 28 proteins that were at least 
1.5 fold differentially expressed between the O and the R strains with 95 % confidence levels.  
However, this approach did not address differences in enzyme activities of the proteins. The results 
of the MS analysis of the 28 differentially expressed proteins are listed in Table 3.1 (see Appendix 
C, Table C1). Most of the proteins analyzed were downregulated in the R strain as compared to 
the O form. Polar flagella proteins, numerous proteins involved in metabolic pathways, 
transcription factors, proteases, elongation factors and uncharacterized proteins displayed varied 
increases or decreases between phases. Genes involved in metabolic functions such as purine 
metabolism, vitamin B5 synthesis, alanine aspartate metabolism, sugar binding proteins and 
uncharacterized protein domains showed an increase in the biofilm-proficient R strain. We have 
identified novel uncharacterized proteins that may be important for biofilm formation.  
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Figure 3.1: 2DGE separation of opaque and rugose V.vulnificus phase variant proteins. (a) Protein 
separation was carried out on 4-7 pH Immobiline strips in the first dimension and 12.5 % 
polyacrylamide gels in the second dimension. Arrows in the representative portion of the gels 
indicate proteins identified by Progenesis software to be differentially expressed between phase 
variants. Inset figures show the biofilm-proficient strain KG3(R) and opaque strain YJ016. (b) Gel 
sub-sections of protein spots identified by Progenesis software to be differentially expressed in the 

















Table 3.1: Mass Spectrometric analysis results of proteins identified by PDQuest to be at least 1.5-
fold differentially expressed with 95 % confidence limits between opaque and rugose phase 
variants of V. vulnificus.   
Spot #  Swissprot Accession #        Description                                       
Exclusively present in Rugose 
5403 Q7MIG1           Elongation factor Ts Vibrio vulnificus YJ016 tsf     
1616    Q8DD27                      Putative elongation factor Tu-like protein Vibrio   
          vulnificus VV1_1204 
1502            No hits                                                           
Increased in Rugose 
1108                 No hits                                                           
2510 Q8D6Q8|ADD_VIBVU      Adenosine deaminase Vibrio vulnificus add     
3504 Q7MHV3           Pantothenate synthetase Vibrio vulnificus YJ016 panC 
7710 Q8D6Q0           Alanine racemase 2 Vibrio vulnificus alr2   
1505    P18815           Maltose binding periplasmic protein  
            Enterobacter aerogenes malE          
4206 Q7MMG7                            ATP dependent Clp protease proteolytic      
                                                         subunit Vibrio vulnificus YJ016 clpP                             
5205    Q7MMT3                      UPF0319 protein VV0984 Vibrio vulnificus  
                                                         YJ016 VV0984       
Decreased in Rugose  
1503 Q56703|FLAA_VIBPA       Polar flagellin A Vibrio parahaemolyticus flaA  
1602 Q56712|FLAC_VIBPA       Polar flagellin C Vibrio parahaemolyticus flaC 
2601 Q56702|FLAB_VIBPA       Polar flagellin B/D Vibrio parahaemolyticus flaB  






(Table 3.1 continued) 
Spot #  Swissprot Accession #        Description                                       
                Vibrio harveyi patH                                                     
4805 Q7MHA5|CYSJ_VIBVY   Sulfite reductase [NADPH] flavoprotein alpha-     
            component Vibrio vulnificus YJ016 cysJ 
2708 Q7MH72           Argininosuccinate synthase Vibrio vulnificus  
                                                        YJ016 argG                                                                                                         
4509  B5FFK8                      o succinylbenzoate synthase Vibrio fischeri menC  
6809 Q8DD27                    Putative elongation factor Tu-like protein  
            Vibrio vulnificus   VV1 1204 
7306 Q7MFN1           Putative hydrolase VVA0289 Vibrio vulnificusYJ016   
             VVA0289 
7510 Q7MMV0           Flagellar P ring protein Vibrio vulnificus YJ016 flgI 
5309 Q8D8X2                      Ribosomal small subunit pseudouridine synthase A                                 
                                                         Vibrio  vulnificus rsuA  
5604 Q7MPS9           Coenzyme A biosynthesis bifunctional protein CoaBC  
                                                         Vibrio  vulnificus YJ016 coaBC 
6808 O64647           Transcription factor TCP9 Arabidopsis thaliana TCP9 
7301 Q7MLU7           Dethiobiotin synthetase Vibrio vulnificus YJ016  bioD  
1601             No hits 
7602             No hits 
3706             No hits 







The results reveal that some putative elongation factors (EFs), were exclusively associated 
with the R form while another one was diminished in this form. Similar results have been observed 
in Streptococcus mutans where EFs increased from 1.9 to 8.1-fold in biofilms as compared to the 
planktonic stage (Svensater, Welin et al. 2001). Since EF-G along with initiation factor 2 (IF2) 
have been reported to act as chaperones to protect E. coli cells from stress (Caldas, Laalami et al. 
2000), there is a possibility that some EF’s are a part of a response to the stressful conditions, 
which are known to induce biofilms in bacteria (O'Toole and Stewart 2005). On the other hand, 
some EFs and ribosomal proteins appear to be downregulated in Streptococcus pneumoniae 
biofilms since biofilm state is considered to be quiescent (Gilbert, Maira-Litran et al. 2002, 
Sanchez, Kumar et al. 2011).  
Adenosine deaminase, Ada, an enzyme involved in purine metabolism which catalyzes the 
conversion of adenosine to inosine, increased in the R form compared to the O parent.  Studies in 
Pseudomonas aeruginosa have reported that supplementation of 10 mM adenosine to the medium 
reduced rhamnolipid and EPS production, thereby preventing swarming and biofilm formation; 
however, the adenosine metabolite, inosine did not inhibit biofilm formation at the same 
concentration (Sheng, Pu et al. 2012). This could explain the increase of Ada in the V. vulnificus 
R form. In contrast, Actinobacillus pleuropneumoniae microarray analysis data has shown that 
tRNA- specific Ada is downregulated in biofilm enhancing media (Labrie, Pelletier-Jacques et al. 
2010). Also in Shewanella oneidensis, 2DGE data has identified a downregulation of Ada in the 
biofilm form compared to the planktonic form (De Vriendt, Theunissen et al. 2005). The 
contradicting phenomena seen in P. aeruginosa, A. pleuropneumoniae and S. oneidensis suggests 






seems to support the inhibitory effect of adenosine on V. vulnificus biofilms but this hypothesis 
needs further experimental validation.  
Pantothenate synthase, PanC, an enzyme involved in vitamin B5 synthesis was expressed 
at higher levels in the R as compared to the O form. Vitamin B5 is required for synthesis and 
metabolism of proteins, fats and carbohydrates. It is also required for coenzyme A (CoA) synthesis, 
which on acetylation forms acetyl CoA. Microarray experiments in Escherichia coli have reported 
that carbon sources, which can be metabolized into acetyl CoA, acetyl phosphate and acetate, 
support biofilm formation. Acetate metabolism in E.coli is a sensory relay of the environmental 
conditions towards biofilm formation (Pruss, Verma et al. 2010), and E.coli cells altered in their 
ability to metabolize acetyl phosphate cannot construct normal biofilms (Wolfe, Chang et al. 
2003). But the direct role of CoA in biofilms is not known (Pruss, Verma et al. 2010). Our results 
also indicate a decrease in the coenzyme A biosynthesis proteins, CoaBC in the R form. These 
results imply that vitamin B5 (pantothenate) may play a role in V. vulnificus biofilm formation but 
perhaps not via coenzyme A synthesis. 
  One of the proteins increased in the R phenotype was identified by MS and Swiss Prot 
analysis to be MalE (maltose-binding periplasmic protein).  RNA dot blots using malE gene as a 
probe exhibited a 2.5 fold increase in malE transcript in KG3(R) as compared to YJ016 (Figure 
3.2). malE (VVA0397) is situated immediately upstream of the brp gene cluster, which is required 
for V. vulnificus biofilm formation, as genes in this cluster are involved in EPS biosynthesis and 
transport (Grau, Henk et al. 2008, Guo and Rowe-Magnus 2010). Comparative microarray analysis 
of biofilm and planktonic E.coli cells has reported malE to be upregulated in biofilms of that 






and metabolism have been reported to be increased in E. coli biofilms (Beloin, Valle et al. 2004). 




Figure 3.2: RNA dot blot hybridization with radiolabeled malE (VVA0397) probe showing 2.5-
fold increased transcription of malE in rugose strain KG3(R) as compared to the opaque variant 
YJ016. gDNA at various concentrations was used as a positive control.  
 
To determine the role of MalE in V. vulnificus rugose colony and biofilm formation, we 
created a polar insertional mutant in malE gene in strain KG3(R) by deleting the functional 











Figure 3.3: PCR verification of malE (VVA0397) mutants obtained by deletion of functional 
domains and insertion of kanamycin cassette. Lanes 1, 15:1 kb+ DNA ladder; 2-11, 13: putative 
transconjugants, 12: negative control, 14: KG3(R) gDNA. 
 
The mutant isolates, ZK-32, ZK-45 and ZK-49 retained the rugose colony phenotype of 
the parental strain (Figure 3.4). This result suggests that malE is not involved in the R phenotype 
or there could be a different gene somehow compensating for the loss of function in malE.  
There does exist another potential maltose binding periplasmic protein (VVA0056 gene 
product) in the genome of YJ016, which is 56 % identical in amino acid composition to MalE 
(VVA0397 gene product). It would be worthwhile to study the effect of the double mutant on 
rugosity.  
While it is known that biofilm formation in Enterococcus faecalis and S. mutans is induced 
by the presence of maltose (Creti, Koch et al. 2006, Klein, DeBaz et al. 2010), it has been 
demonstrated in V. vulnificus and Vibrio cholerae that maltose inhibits biofilm formation (Ali, 
Morris et al. 2005, Kim, Park et al. 2009). 
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Figure 3.4: malE (VVA0397) is not involved in the rugose phenotype of V. vulnificus. Mutants in 
malE were created by deleting the functional domains and inserting a kanamycin resistant marker 
in the open reading frame (ORF) of VVA0397. All the three malE mutant isolates (ZK-32, ZK-45 
and ZK-49) constructed retained the rugose phenotype of the parent KG3(R) strain.  
 
It is possible that other products transported through the malEFG operon may act as a signal 
for biofilm formation. In E. coli, the presence of maltotriose in the medium, which is also 
transported by the malEFG products, results in increased biofilm formation (Mugabi, Sandgren et 
al. 2012).  It is also possible that byproducts of maltose or maltodextrin hydrolysis such as glucose 
may serve as a structural component of the EPS matrix.  The EPS and CPSA polysaccharides, 
which are responsible for biofilm and pellicle formation in V. cholerae and Vibrio 
parahaemolyticus, respectively, are known to be composed of glucose and various other sugars 
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(Yildiz and Schoolnik 1999, Enos-Berlage and McCarter 2000, Enos-Berlage, Guvener et al. 2005, 
Yildiz, Fong et al. 2014). Since the EPS composition of V. vulnificus has not yet been clearly 
determined, it would be worthwhile to know if maltose or its breakdown product, glucose, acts as 
a building block of the EPS matrix. In S. mutans, though maltose has not directly been shown to 
be a part of the biofilm matrix, maltose/ maltotriose transport genes are transcriptionally 
upregulated at various stages in biofilm development in media containing a combination of starch 
and sucrose compared to sucrose only (Klein, DeBaz et al. 2010). In E.coli, maltose gets converted 
to acetyl coA, accumulation of which results in increased biofilm formation (Mugabi, Sandgren et 
al. 2012).  
Alanine racemase, Alr2, which is involved in alanine and aspartate metabolism, by 
catalyzing the racemization of L-alanine to D-alanine, was increased in the R form compared to 
the O. Our result is consistent with a report in which D- alanine promoted biofilm formation in 
Bacillus subtilis, P. aeruginosa and Staphylococcus aureus, whereas the other D- amino acids 
promoted biofilm disassembly (Kolodkin-Gal, Romero et al. 2010) due to their toxic effects on 
protein synthesis (Leiman, May et al. 2013).  Furthermore, D-alanine esters of lipoteichoic acids 
are known to promote biofilm formation in E. faecalis (Fabretti, Theilacker et al. 2006).  
Expression of an ATP-dependent proteolytic subunit of ClpP was also induced in the R 
form. Clp (caesinolytic proteases) are serine proteases, which, in S. aureus, have been shown to 
be required for stress tolerance and biofilm formation (Frees, Chastanet et al. 2004). ClpP proteins 
are also enhanced in Campylobacter jejuni biofilms (Kalmokoff, Lanthier et al. 2006). Mutations 
in ClpP protease genes in Pseudomonas fluorescens and S. mutans inhibited biofilm formation 






Our study also identified spot 5205, (i.e. the gene product of VV0984), which is an 
uncharacterized protein, to be induced in the R phenotype. This is a 245 amino acid hypothetical 
protein, harboring DUF 2057 domain, which is present in prokaryotes but its function is yet 
unknown. Further studies characterizing the function of this protein and establishing what role it 
plays in biofilm formation would be very interesting.   
Polar flagellar basal body proteins FlaA, FlaB/D and FlaC and flagellar P ring protein, FlgI 
were downregulated in the R form compared to the O form. Reduction in motility by other R V. 
vulnificus strains compared to the O and T forms has been previously observed in 0.3 % agar but, 
interestingly, the single polar flagellum was retained and cells were able to swim actively in 
phosphate buffered saline (Grau, Henk et al. 2005).  Biofilm formation begins with bacteria 
actively swimming and attaching to a surface. After the initial attachment, microcolony and 3D- 
architecture formation begins due to the growth and movement of the attached bacteria. In V. 
cholerae, flagellar mutants showed reduced attachment to substrate but they retained the ability to 
form vps-dependent biofilms if sufficient time was provided (Yildiz and Visick 2009). In contrast, 
flagella mutants in Listeria monocytogenes and E. coli were defective in biofilm formation as 
flagella are required in the initial attachment step and during later parts of developments of biofilm 
architecture in those species (Pratt and Kolter 1998, Lemon, Higgins et al. 2007). In P. aeruginosa, 
flagella are not required for the initial attachment step but mutations in flagellar genes can produce 
biofilms with different structures by affecting biofilm development (Klausen, Heydorn et al. 2003). 
These different roles of flagella do underline the diversity of mechanisms used by different bacteria 






A putative amino acid transport ABC binding protein, PatH was downregulated in the R 
form which is consistent with reports of reduction in ABC transporters in the rugose V. cholerae 
strains (Yildiz, Liu et al. 2004). Arginosuccinate synthase, ArgG, is the penultimate enzyme in 
arginine synthesis, catalysing arginosuccinate formation from citrulline and aspartate. Our data 
showed that ArgG is reduced in the R form. Also, ArgG was reduced in biofilms as compared to 
planktonic cells in Desulfovibrio vulgaris (Clark, He et al. 2012).  
  Expression of sulfite reductase, CysJ was reduced in R forms as compared to the O form. 
Sulfite reductase catalyzes the formation of hydrogen sulfide from sulfite and is involved in 
sulphur assimilation and selenocysteine metabolism. Biofilms formed by wild type E.coli cells in 
LB were similar to a cysJ mutant, which implies that cysJ does not contribute to E.coli biofilm 
formation in that medium (Domka, Lee et al. 2007).  
Succinylbenzoate synthase, MenC, produces o-succinylbenzoic acid, which is the first 
intermediate in the vitamin K2 (menaquinone) biosynthetic pathway. Menaquinone plays a role as 
an electron carrier during respiration, but it is also a signal for communicating redox status to two-
component regulatory systems (Georgellis, Kwon et al. 2001). In E.coli, menC was identified as 
being important in biofilms (Junker, Peters et al. 2006).  
VVA0289 a hydrolase, harboring the histidinol phosphatase domain, was reduced in the R 
form as compared to the O form. Microarray analysis data in E.coli has shown that the hisB gene, 
encoding a bifunctional imidazole glycerol phosphate dehydratase/ histidinol phosphatase was 
induced 1.5 fold in biofilms subjected to 5-flurouracil (5-FU) (Attila, 2009). However, this study 
also found that biofilm formation in the hisB mutant was increased compared to the wild type 






Our data also demonstrated that ribosomal small subunit pseudouridine synthase A was 
downregulated in the R form compared to the O. Pseudouridine synthases are the enzymes 
responsible for posttranscriptional modification of cellular RNAs by catalyzing the site-specific 
isomerization of uridine residues that are already part of an RNA chain (Hamma and Ferre-
D'Amare 2006). In P. aeruginosa, it has been reported that uracil-related mutations abolished 
biofilm formation (Ueda, Attila et al. 2009). In Leptospirillium Group B and E.coli, pseudouridine 
synthase B and C, respectively, increased in the initial stages of biofilm (Ito, Taniuchi et al. 2009, 
Mueller, Dill et al. 2011). Finally, our study demonstrated that dethiobiotin synthase, BioD, an 
enzyme that synthesizes dethiobiotin and is involved in biotin metabolism, was decreased in the R 
form compared to the O. In contrast, in E. coli, the bioD gene, is upregulated in the early stages of 
biofilm formation (Ito, Taniuchi et al. 2009). On whole, the differences observed in our data and 
some of the previously reported studies underline the diverse mechanisms and strategies utilized 
by the bacterial world to promote biofilm formation. 
MATERIALS AND METHODS 
Strains and growth conditions: V. vulnificus strain, YJ016 - an opaque clinical isolate 
from Taiwan (Chen, Wu et al. 2003) and its spontaneous rugose derivative, KG3(R) (Garrison-
Schilling, Kaluskar et al. 2014) were stored at -70 °C in heart infusion broth (Difco) supplemented 
with a total of 2 % NaCl (HI) and 15 % glycerol. V. vulnificus strains were streaked on HI agar 
supplemented with 18g/L non granulated agar (Difco) and incubated at 30 °C overnight (ON) for 
16-24 hours for single colony isolation. Broth cultures were propagated in HI broth at 30 °C and 
200 rpm ON. E. coli strains were stored at -70 °C in Luria-Bertani (LB) broth (Difco) 






granulated agar (Difco) and incubated at 37 °C ON for single colony isolation. Broth cultures were 
propagated in LB broth at 37 °C and 250 rpm ON. Antibiotics (Sigma) were used as follows when 
needed: 50µg/ml ampicillin and 150µg/ml kanamycin for V. vulnificus and 50µg/ml ampicillin and 
50µg/ml kanamycin for E. coli. Strains and plasmids used in this study are listed in Tables 3.2 and 
3.3 respectively.  
 
Table 3.2: Strains used in this study 
     Strain          Genotype/Description      Reference 
E.coli 
   SY327λpir ∆(lac pro) argE(Am) rif malA                      (Miller and Mekalanos 1988) 
  recA56 λpir 
   S17.1λpir     thi pro hsdR hdsM+ recA                                     (Simon, Priefer et al. 1983) 
                        RP4-2-Tc::Mu-Km-Tn7 λpir 
V. vulnificus  
   YJ016 encapsulated, opaque clinical strain, Taiwan             (Chen, Wu et al. 2003) 
   KG3(R)       isogenic rugose phase variant               (Garrison-Schilling, Kaluskar 2014) 
                        obtained from YJ016                                    
   ZK-32          polar mutant of malE in KG3(R), KanR                                   This study 
   ZK-45 polar mutant of malE in KG3(R), KanR                                 This study 









Table 3.3: Plasmids used in this study 
Plasmid   Description         Source/Reference 
   pSP72                cloning vector, AmpR                                                              Promega   
   pGP704sacB      suicide vector, AmpR                                                             (Lim, Beyhan et al. 2006) 
   pVV67               malE fragment cloned in pSP72, AmpR                        This study 
   pVV71               nonpolar KanR cassette inserted in the malE            This study   
                              fragment of pVV67, AmpR, KanR                                     
   pVV74               malE-KanR cassette from pVV71 cloned into          This study 
                              pGP704sacB, AmpR, KanR 
 
 
Protein extraction: All chemicals used were of analytical grade. Tricarboxylic acid 
(Sivaraman, Kumar et al. 1997) sodium dodecyl sulfate (SDS), iodoacetamide (IAA) were 
purchased from Sigma. Methanol, ammonium acetate, acetone, glycerol, sodium phosphate and 
potassium phosphate were purchased from Mallinckrodt (St. Louis, Missouri). Immobiline Dry 
Strip (pH 4.0 to 7.0, nonlinear 18 cm) and dithiothreitol (DTT) were purchased from GE 
Healthcare Biosciences. Tris, bromophenol blue, ethylenediaminetetra acetic acid (EDTA), 
phenol, beta mercaptoethanol (β-ME), urea, 3-([3-Cholamidopropyl]-dimethyl-ammonio)-1-
propane-sulfonate) (CHAPS), ammonium persulfate (APS) and N,N,N9, N9,-tetramethyl-
ethylenediamine (TEMED) were purchased from Amresco. Surcose and Pefabloc were purchased 
from Matheson, Coleman and Bell and Roche, respectively.  
Proteins were extracted from at least 3 different cultures started from 3 independent single 






correct morphology into 3 ml HI broth. This culture was termed the ON. The ONs were then 
subcultured 1:100 in fresh HI medium and grown until mid-exponential phase (OD600 between 0.4 
and 0.6). Upon reaching desired OD600, broth cultures were again subcultured 1:100 into 250 ml 
HI broth and cells were harvested at mid-exponential phase by centrifugation at 4,332 x g for 10 
min at room temperature (RT). Cells were washed by centrifugation at 4,332 x g for 5 min twice 
in 5ml 1 X PBS buffer and pellets were then resuspended in 5 ml lysis buffer (10 mM Tris HCl 
pH 8.0, 5 mM EDTA, 1mM Pefabloc). Cell pellets were disrupted by sonication (3 x 10 pulses at 
setting 3). Mixtures were then centrifuged at 4,472 x g for 10 min at 4 °C. In case a cell pellet was 
seen, the mixture was sonicated again to lyse all the cells. Proteins in the supernatant were 
precipitated with TCA (final concentration of 10 %) and incubated on ice for 30 min. Precipitated 
proteins were collected by centrifuging at 14,881 x g for 15 min. To the precipitate, 2.5 ml/g of 
Tris-saturated phenol (pH 8.0) and 2.5 ml of SDS extraction buffer (2 % SDS, 30 % sucrose, 0.5 
% βME) were added. Samples were mixed by vortexing for 1 min and then placed on ice for 1 
min. This process was repeated for a total of 15 times. Mixtures were then centrifuged at 14,881 x 
g for 10 min at 4 ºC. To the upper phenol phase, 20 ml of 80 % methanol containing 0.1 M 
ammonium acetate (Hurkman and Tanaka 1986) was added and stored at -30 ºC overnight . The 
mixture was then centrifuged at 14,881 x g for 30 min (4 ºC). Supernatants were then discarded 
and pellets were washed with 10 mL 100 % methanol by chopping the pellets and vortexing for 3 
min.  Mixtures were then spun at 14,881 x g for 20 min at 4 ºC. Supernatants were discarded and 
pellets were washed with 80 % acetone by chopping and vortexing for 3 min. Mixtures were 
centrifuged at 14,881 x g for 20 min at 4 °C and the supernatants were discarded. Protein pellets 






Two dimensional gel electrophoresis (2DGE): A small amount of protein pellet (20-50 
mg) was resuspended in 100 µl of lysis buffer (8M Urea,  4 % w/v CHAPS, 40 mM DTT,  2 % 
v/v 4-7 IPG buffer in deionized water) and allowed to sit at RT for at least 30 min before it was 
disrupted to dissolve. Protein concentration was measured at OD595 by the Bradford method using 
Bio-Rad Protein Assay Dye.  The mixture was then spun in a table top centrifuge at 2410 x g for 
10 min at RT to remove the undissolved proteins. Protein (150 µg) dissolved in lysis buffer was 
added to IPG Strip rehydration buffer (Urea 8 M, Bromophenol blue trace, 2 % (w/v) CHAPS, 0.5 
% 4-7 IPG buffer, 20 mM DTT in deionized water) such that the total volume was 340 µl for an 
18 cm strip. Strip rehydration was carried out by placing the above 340 µl solution in each lane of 
a rehydration tray. The gel side of the 4-7 IPG strips was placed face down to directly contact the 
solution to avoid bubbles. The strips were covered with 2-3 ml Dry Strip cover fluid to prevent 
drying. Rehydration was carried out for at least 12 hrs at RT. Isoelectrofocussing  (IEF) was carried 
out at 20 °C with 500 V for 1.5 hrs, and then with 1000 V for 1.5 hrs, and finally at 8000 V for 5 
hrs. After IEF was completed, strips were equilibrated as follows: (a) 40 min of slow shaking at 
RT in SDS equilibration buffer containing DTT (50 mM Tris HCl, pH 8.8, 6 M urea, 30 % (v/v) 
glycerol, 2 % (w/v) SDS, 1 % bromophenol blue, 1 % DTT in deionized water) (b) 50 min of slow 
shaking at RT in SDS equilibration buffer containing IAA (50 mM Tris HCl, pH 8.8, 6 M Urea, 
30 % (v/v) glycerol, 2 % (w/v) SDS, 1 % Bromophenol blue, 2.5 % IAA, in deionized water). 
Second dimension electrophoresis was carried out at 18 °C in 12.5 % acrylamide gels for 1 hr 40 
V and then 15 hrs at 120V (Laemmli 1970). Analytical gels were stained with Dodeca silver stain 
kit (Bio-Rad), scanned with UMAX PowerLook II scanner (UMAX data systems, Taiwan), and 






were stained with SYPRO Ruby (Bio-Rad) according to the manufacturer instructions, and then 
scanned and analyzed by PDQuest software (Bio-Rad) at the Pennington Biomedical Research 
Center.  
Spot excision and in-gel tryptic digestion: Briefly, 2-mm gel plugs were excised 
automatically using ProteomeWorks spot cutter (Bio-Rad) and deposited in a 96-well plate. In-gel 
tryptic digestion was performed using an automated robotic workstation (MassPrep, Waters 
Corp.). Gel plugs were washed with NH4HCO3 and CH3CN followed by reduction and alkylation 
using 10 mM DTT and 55 mM IAA, respectively. Proteins were cleaved by sequencing grade 
trypsin (150 ng/gel plug) at 37 °C ON.  The peptide fragments were extracted with 2 % CH3CN 
and 1 % HCOOH in water and directly analyzed using liquid chromatography (LC) – tandem mass 
spectrometry (MS/MS) (Zvonic, Lefevre et al. 2007), at the Pennington Biomedical Research 
Center, LA. 
Protein identification using LC-MS/MS: The peptides from each digested spot were 
separated and analyzed using a capillary LC system coupled on-line with a nanospray quadrupole 
time-of-flight (Q-TOF) MS (Waters, Corp.) as described previously (Zvonic, Lefevre et al. 2007).  
Tandem mass spectra were analyzed using the ProteinLynx Global Server (PLGS) 2.2.5 software 
(Waters, Corp.) against the Swiss Prot database.  The database search settings included one missed 
tryptic cleavage and fixed carbamidomethylation of cysteine residues (Zvonic, Lefevre et al. 
2007).  In some cases, MS/MS data was also identified using MASCOT search engine (Perkins, 
Pappin et al. 1999). De novo sequencing from MS/MS data was also performed using Peaks 






Protein sequence analysis for MalE: Proteins identified by Swiss Prot were BLASTed 
against the genome sequences of V. vulnificus in the National Center for Biotechnology 
Information (NCBI) database using Basic Local Alignment Search Tool (BLAST) (Altschul, 
Madden et al. 1997). 
Genetic manipulation techniques: Standard DNA techniques were carried out using 
molecular protocols (Sambrook, Fritsch et al. 1989). Restriction enzymes, calf intestinal alkaline 
phosphatase (CIP), T4 DNA polymerase and Klenow polymerase were obtained from New 
England BioLabs. Pfu polymerase, Amplitaq and primers were obtained from Stratagene, Applied 
Biosystems and Sigma Genosys, respectively.  
Generation of malE insertion mutant: Polymerase chain reaction (PCR) was performed 
to amplify a 1853 bp fragment with XbaI ends (underlined) using YJ016 gDNA as template and 
primers MalEF (5′-AAAAATCTAGAACTCGCCTACATCCTCCTAC-3′) and MalER (5′-
AAAAATCTAGAAAATCATCCCGGCAATACCC-3′). Each 50-µl PCR reaction contained 5 µl 
of 10X buffer, 4 µl of 10 mM dNTP mixture (each at a 2.5 mM concentration), 1 µl each of the 20 
µM primers, 1 µl of 2.5 U/µl Pfu polymerase, 100 ng YJ016 gDNA and nuclease free water to 
make up volume. The PCR cycle conditions were as follows: 95 °C for 2 min, followed by 30 
cycles of 95 °C for 45 sec, 55 °C for 45 sec, and 72 °C for 1.5 min. A final extension step consisted 
of 72 °C for 10 min and final hold was at 4 °C. PCR reactions were analyzed by agarose gel 
electrophoresis. Cleaned products were cloned into the XbaI site of pSP72 (Promega) to create 
pVV67. The insert sequence of pVV67 was sequenced using BigDye v3.1 (Applied Biosystems) 
and primers MalEF, MalER, MalESeqF (5′-GCGCTGCAAGATAAATTCCC-3′) and MalESeqR 






2011). pVV67 was then double digested with AfeI and NsiI to delete the functional domain of the 
malE gene. An 840-bp, blunt-ended, nonpolar kanamycin-resistant cassette, generated by SmaI 
digestion,  (Menard, Sansonetti et al. 1993) was then cloned into the AfeI, NsiI sites after they were 
made blunt ended by using T4 DNA polymerase and nucleotides to remove 3′ overhangs, in order 
to create pVV71. The ~ 1.6-kb XbaI fragment of pVV71 was then cloned into the XbaI site of 
pGP704sacB (Lim, Beyhan et al. 2007) to create pVV74, which was maintained in E. coli strain 
SY327λpir and later transformed into E. coli S17.1λpir. Matings were carried out between KG3(R) 
and S17.1λpir on membrane filters. Ampicillin-sensitive, kanamycin-resistant transconjugants, 
which had undergone double homologous recombination, were selected. Mutants were confirmed 
by polymerase chain reaction (Grau, Henk et al. 2008) using Amplitaq and primers MalEF and 
MalER.  
RNA dot blot analysis: Total RNA extraction and dot blot hybridization were conducted 
as previously described (Grau, Henk et al. 2008), with the only modification being that 5 µg, 500 
ng and 50 ng RNA samples were used for each strain. PCR reactions were performed with primers 
malE-For (5′-GGGCAACATTGAGAAGTCTG-3′) and malE-Rev (5′-
GTTTGACGACCATCCACTAC-3′) and strain YJ016 gDNA to generate a 372-bp probe for the 
hybridization reactions. The PCR-amplified, VVA0397 (malE) probe was radiolabeled using the 
NEBlot random priming kit (New England BioLabs) and [α-32 P] dATP (3,000 Ci/mmol). 
Approximately 108 cpm of radiolabeled probe was used for hybridization as described earlier 
(Grau, Henk et al. 2008). Briefly, dot blots were exposed to a phosphor screen for 2 hrs at RT. The 
screen was then scanned with a Typhoon scanner (GE Healthcare, Piscataway, NJ). Image 






levels were calculated by dividing the sum of the pixel values above the background level for each 






























DISTRIBUTION STUDIES OF THE wcr (brp) GENE CLUSTER IN V. VULNIFICUS 
 
INTRODUCTION 
Vibrio vulnificus (V. vulnificus), is a bacterium inhabiting estuarine warm waters around 
the world. In these natural habitats, it is found at high concentrations in the guts of filter feeding 
mollusks such as shrimp, lobsters and oysters, in the sediments and also in the water column. Being 
a human pathogen, it is known to have the highest mortality rate among seafood pathogens (Gulig, 
Bourdage et al. 2005, Oliver 2013). Pathogenesis is directly correlated to the presence of capsular 
polysaccharide (CPS) which aids in bacterial defense from the human immune system (Linkous 
and Oliver 1999, Simpson, White et al. 1987, Strom and Paranjpye 2000, Yoshida, Ogawa et al. 
1985). Diseases in humans are caused by consumption of raw seafood, especially oysters and also 
by contact of skin abrasions to seawater or seafood drippings. Virulent encapsulated opaque (O) 
colony forming strains undergo capsular phase variation, which results   in avirulent, translucent 
(T) colony forming strains that are acapsular or greatly reduced for capsule production (Yoshida, 
Ogawa et al. 1985, Simpson, White et al. 1987, Wright, Powell et al. 2001). The opaque and the 
translucent strains can undergo further phase variation which results in production of a separate 
exopolysaccharide (EPS) and rugose (R) colonies. The R phenotype can form abundant biofilms 
under certain laboratory conditions. (Grau, Henk et al. 2005, Grau, Henk et al. 2008, Garrison-
Schilling, Grau et al. 2011).   
Rather than living as single solitary entities, bacteria in the environment are known to exist 
in biofilm communities. The biofilm matrix, which is typically composed polysaccharides, 
proteins and extracellular DNA, confers advantages like nutrient sequestration, protection from 






association with mollusks like oysters, V. vulnificus is thought to exist in its opaque encapsulated 
form but when present in the water column or in the sediments, it is thought to be present in the 
rugose form (Srivastava, Tucker et al. 2009). Consequently, biofilm formation, capsule formation 
and thereby polysaccharide production seem to be processes of prime importance in V. vulnificus.  
A number of loci involved in CPS and EPS expression have been identified though most 
may not be highly conserved among V. vulnificus strains based on the genomic analysis to date. 
One known exception to this is the group I CPS operon, which is conserved in various V. vulnificus 
strains (Wright, Powell et al. 2001), including the sequenced strains (Chen, Wu et al. 2003, Park, 
Cho et al. 2011). It is at this locus where deletions of the wzb gene, caused by homologous 
recombination between flanking direct repeats, resulted in strains that remained locked in the 
translucent phase (Chatzidaki-Livanis, Jones et al. 2006, Garrison-Schilling, Grau et al. 2011). 
Another potentially conserved locus is the nine-gene brp (formerly wcr) cluster, which was 
expressed at higher levels in the R forms compared to the O and T (Grau, Henk et al. 2008, Guo 
and Rowe-Magnus 2010). This locus encodes determinants for EPS expression (and thus efficient 
biofilm formation) and is present in all the three sequenced strains of V. vulnificus as well as the 
clinical isolate 1003(O).  Since many of the brp genes are required for rugosity and efficient 
biofilm formation, we also hypothesized that this locus likely provides a survival advantage in the 
environment, and, as such, it would be predicted to be well-conserved among strains of this 
species.  This possibility was tested by screening for the presence of the brp cluster in a number 
of clinical and environmental strains. Here, we have analyzed the distribution of this cluster among 






and have found that the brp genes are widespread and seem to be evolutionarily conserved in this 
species  (Garrison-Schilling, Kaluskar, 2014). 
RESULTS AND DISCUSSION 
The brp locus is well conserved in V. vulnificus. Linkage PCR was performed as 
previously described (Grau, Henk et al. 2008) to determine that 32 of the 33 V. vulnificus strains 
in our laboratory collection contained the brp locus with no insertions or deletions (Table 4.1).  As 
a comparison, all 32 strains also showed evidence of the well-conserved Group I CPS operon 
(Wright, Powell et al. 2001, Chatzidaki-Livanis, Jones et al. 2006) based on the presence of an 
intact wzb gene. The lone exception was the environmental isolate MLT198, which lacked both 
the wzb gene and the brp cluster (Table 4.1), and was therefore unable to form any translucent or 
rugose colonies, respectively (Table 4.2). To further characterize the brp genes in the 32 strains, 
Southern blot hybridization was performed, which showed that 18 of the 32 brp+ strains were of a 
single 10.5 kb PstI restriction fragment length polymorphism (RFLP) profile (Table 4.1).  The 
exact profile of the other 14 could not be determined from the available data. An additional nine 
recently-isolated environmental V. vulnificus strains were also analyzed for the brp cluster and all 
were found to be brp+ by linkage PCR analysis (Table 4.1). Interestingly, Southern blot 
hybridization profiles of these strains revealed two distinct PstI RFLP profiles: a 10.5 kb band 
(observed in 18 of the originally tested strains) or a 2.7 kb band, which was not present in the 
original 32 strains (Table 4.1, Figure 4.1). The presence of all brp genes as determined by PCR 
analysis  coupled with the occurrence of the 2.7 kb RFLP band in 6 out of the 9 newly isolated 
strains tested indicated that there could have been base changes in these strains which resulted in 






Table 4.1: V. vulnificus strains were analyzed by PCR and Southern hybridization for the brp 
cluster and by PCR for the wzb gene. 
     Presence of brp    Presence 
                                              cluster            of wzb 
       Linkage    Southern2      PCR1 
Strain           PCR1              (kb)          
Lab strains 
1001   +         10.5             + 
1003(O)  +                  10.5     + 
1004   +          10.5             + 
1005    +          10.5             + 
1007   +            -      + 
1009                 +            -      + 
1014   +            -      + 
1456(O)  +         10.5      + 
1456(T)  +            -      + 
1657(O)  +            -      + 
1657(T)  +            -      + 
95-10-15  +         10.5      + 
96-7-155  +            -      + 
ABZ1(R)  +            -      + 
ABZ1(T)  +            -      + 
ATCC27562  +         10.5      + 
AZ(T)   +            -      + 
BG(R)   +            -      + 






(Table 4.1 continued) 
     Presence of brp    Presence 
                                              cluster            of wzb 
       Linkage    Southern2       PCR1 
Strain           PCR1              (kb)          
CMCP6  +            -      + 
CPClam2  +         10.5      + 
CPMussel10  +            -      + 
CPSed5  +         10.5      + 
F8Oyster11(O) +         10.5      + 
F8Oyster11(T) +         10.5      + 
KG3(R)  +         10.5      + 
KG4(T)  +         10.5      + 
MLT124  +         10.5      + 
MLT136(O)   +         10.5      + 
MLT136(T)  +         10.5      + 
MLT141  +         10.5      + 
MLT198  -            -      - 
YJ016   +         10.5      + 
Newly isolated strains 
132a1   +         10.5      ND 
132z2   +           2.7      ND 
212b6   +           2.7      ND 
212f15   +           2.7      ND 
212s7   +           2.7      ND 






(Table 4.1 continued) 
     Presence of brp    Presence 
                                              cluster            of wzb 
       Linkage    Southern2         PCR1 
Strain           PCR1              (kb)          
342s6   +           2.7      ND 
NOLA18  +            -      ND 
212f18   +           2.7      ND 
1 + or – indicates the presence or absence, respectively, of all genes in the brp cluster (first column 
of data) or the wzb gene (third column of data). 
2 Indicates the size of the band hybridized to a radiolabeled probe specific for brpC (lab strains) or 
brpI (newly isolated strains).  A ҅–҆ indicates that either no bands were present or that band size 
could not be determined. 
ND, not determined. 
 
Table 4.2: Strain MLT198, which lacks both the wcr (brp) genes and the wzb gene, is unable to 
phase switch to either the rugose or the opaque phenotype. Phenotypic switching assays were 
performed on MLT198 and BGT1 in HI broth. Data presented are the means and standard 
deviations of at least 3 independent trials. 
 
Parent strain  % of total colonies with the following phenotypes (Avg. ± SD)a 
             O    R   T 
MLT198       0.00            0.00    99.90 ± 0.10b 
BGT1 16.90±18.90      15.20 ± 18.60             63.90±19.30 
a Total percentage of colonies does not equal to 100 because some colonies had an intermediate 
phenotype. 






As previously seen for strains with the 10.5 kb RFLP profile, strains with the 2.7 kb profile 
also retained the ability to switch to the rugose phenotype (Figure 4.2) and they produced pellicles 
in culture (data not shown). 
Overall, the presence of the brp cluster in 41 out of 42 strains provides direct evidence that 





Figure 4.1: Southern hybridization showing 10.5 and 2.7 kb RFLP profiles of different V.vulnificus 















Figure 4.2: Switching assays were performed on strain 212f15 in HI medium. Data presented are 
the means and standard deviations of at least 3 independent trials. 
 
MATERIALS AND METHODS 
Bacterial strains & growth conditions: All V. vulnificus strains used in this study are 
listed in Table 4.3 and were grown in heart infusion broth (HI) (Difco) supplemented to 2% NaCl 
and on HI agar plates containing 18 g/l of agar (Difco).  Broth cultures were incubated at 30C and 
200 rpm overnight (ON) for 16-24 hours; plates were incubated ON for 16-24h at 30C. To confirm 
their identity, recent isolates of V. vulnificus were first grown on CHROMagar Vibrio 
(CHROMagar) and TCBS agar (Difco), followed by 16S rRNA gene sequencing as described 


























Table 4.3: V. vulnificus strains used in this study 
Strain   Description            Source 
10011,2   blood isolate, opaque            (Martin and Siebeling 1991) 
1003(O) 1,2 formerly 1003; wound isolate from Louisiana,        (Martin and Siebeling 1991) 
  opaque 
10041,2  stool isolate, opaque            (Martin and Siebeling 1991) 
10051,2  blood isolate, opaque           (Martin and Siebeling 1991) 
10071,2  blood isolate, opaque                       (Martin and Siebeling 1991) 
10091,2  blood isolate, opaque           (Martin and Siebeling 1991) 
10141,2   blood isolate, opaque           (Martin and Siebeling 1991) 
1456(O) 1,2 unknown origin, opaque     Lab collection 
1456(T) 1,2 spontaneous translucent variant of 1456(O)   Lab collection 
1657(O) 1,2 unknown origin, opaque     Lab collection 
1657(T) 1,2 spontaneous translucent variant of 1657(O)   Lab collection 
95-10-151,2 unknown origin, opaque     Lab collection 
96-7-1551,2 eel isolate, opaque      Lab collection 
ABZ1(R) 1,2 spontaneous rugose isolate of ABZ1(T)   (Grau, Henk et al. 2005) 
ABZ1(T) 1,2  transposon mutant of 1003(O)                              (Zuppardo and Siebeling 1998) 
  (wcvA::mini-Tn10), translucent 
AZ(T) 1,2 spontaneous translucent isolate of 1003(O)    (Zuppardo and Siebeling 1998) 
BG(R) 1,2 spontaneous rugose isolate of 1003(O)               (Grau, Henk et al. 2005) 
C71841,2 clinical isolate, opaque        (Zakaria-Meehan, Massad et al. 1988) 
CMCP61,2 clinical isolate, opaque                    (Kim, Lee et al. 2003) 
CPClam21,2 oyster isolate, opaque       Lab collection 
CPMussel101,2 oyster isolate, opaque      Lab collection 






(Table 4.3 continued) 
Strain   Description       Source 
F8Oyster11(O) 1,2 oyster isolate, opaque      Lab collection 
F8Oyster11(T)1,2 spontaneous translucent variant of F8Oyster11(O)  Lab collection 
KG3(R)1,2    spontaneous rugose isolate of YJ016  (Garrison-Schilling dissertation,  
         LSU, 2011) 
KG4(T) 1,2    spontaneous translucent isolate of YJ016  (Garrison-Schilling dissertation,  
         LSU, 2011) 
MLT1241,2    oyster isolate, opaque         (Garrison-Schilling, Grau et al. 2011) 
MLT136(O)1,2    formerly MLT136, oyster isolate, opaque   (Garrison-Schilling, Grau et al. 2011) 
MLT136(T)1,2    spontaneous translucent isolate of MLT136(O)   Lab collection 
MLT1411,2    oyster isolate, opaque      Lab collection 
MLT1981,2    sediment isolate, translucent     Lab collection 
YJ0161,2    clinical isolate from Taiwan, opaque     (Chen, Wu et al. 2003) 
Newly isolated strains 
132a11  environmental isolate, opaque     M. E. Janes 
132z21  environmental isolate, opaque     M. E. Janes 
212b61  environmental isolate, opaque     M. E. Janes 
212f151  environmental isolate, opaque     M. E. Janes 
212f181  environmental isolate, opaque     M. E. Janes 
212s71  environmental isolate, opaque     M. E. Janes 
324e91  environmental isolate, opaque     M. E. Janes 
342s61  environmental isolate, opaque     M. E. Janes 
NOLA181 environmental isolate, New Orleans, LA, opaque   Lab collection 
1 strains used for brp distribution analysis 







Switching assays: Phase switching assays in HI were performed as previously described 
(Garrison-Schilling, Grau et al. 2011). Single isolated colonies were inoculated and grown ON in 
HI broth for 16-24 hours with shaking at 200 rpm, 30°C. ON’s were then subcultured 1:100 into 3 
ml of fresh HI broth daily for a total of 15 days and grown as mentioned above. Each subculture 
was termed a passage. Occurrence of phase variation was assayed by plating serial dilutions of 
each culture onto HI agar after ON and every fifth passage. Phenotypes were scored as opaque 
(O)- capsule producing colonies, translucent (T)- colonies with no capsule production, rugose (R)- 
dry wrinkled colonies, sectored (S)- two phenotypes in one colony, others(Ot)- colonies which 
exhibit intermediate capsule production and any other phenotype not categorized above. Percent 
switching frequencies were calculated by using the formula: 100 * (number of colonies of a 
particular phenotype divided by the total number of colonies counted for that particular passage).   
 Molecular genetic and recombinant DNA techniques: DNA manipulations were carried 
out using standard molecular techniques (Sambrook, Fritsch et al. 1989). Restriction enzymes, 
were obtained from New England Biolabs, Pfu polymerase from Stratagene, AmpliTaq 
polymerase from Applied Biosystems, and primers (Table 4.4) from Sigma Genosys. Genomic 
DNA was isolated and PCRs for brp gene linkage analysis and for the wzb gene were completed 
all as described (Grau, Henk et al. 2008, Garrison-Schilling, Grau et al. 2011). Briefly, 100 ng of 
gDNA was amplified in a 25 µl reaction consisting of 2.5 µl 10X PCR buffer, 10% DMSO, 2 µl 
10 mM total DNTP’s, 1.5 µl 25 mM MgCl2, 1.25 µl each of  20 µM primers and 0.2 µl of 5U/ µl 
Amplitaq. PCR reactions were performed as follows: initial denaturation for 94°C -1 min, followed 
by 35 cycles of 94°C -1 min, 55 °C -1 min, 72 °C -2 min, and a final extension of 72°C -5 min and 






were generated via PCR with primer pairs RUG17/RUG18, RUG33/RUG34, CAP25/CAP26, and 
RUG43/RUG44, respectively. Production of radiolabeled probes and hybridizations were 
performed as described (Grau, Henk et al. 2008) using ca. 108 cpm/ml of probe per hybridization.   
 
Table 4.4: Primers used in this study 
Primer  Sequence (5′3′)   Description 
RUG131 CGAGAGAGATGAGAGCAATG Used to demonstrate brpA-brpB linkage 
RUG161 TTCCTCTCGCAATACGCCAC  
 
RUG151 CAAGAGCATACGACCTGGAC      Used to demonstrate brpB-brpC linkage 
RUG181 TGGCGAGGATGACTTATCAA 
 
RUG191 ACGCAGACCTCCACTAGAGA       Used to demonstrate brpD-brpF linkage 
RUG341 GAAGGTGCAGGAAGAGTTGA 
 
CAP251 GTAGAGTGGCAGATCGTACA       Used to demonstrate brpH-brpI linkage 
CAP281 TGTCACGCAACTGCTGTTCT 
 
CAP271 TACCAATCTAACGCCGGCAA       Used to demonstrate brpI-brpJ linkage  
RUG451 AATCCAATGAGCAGCGAAGTCC     (CAP27 also used with CAP28 to  
       generate brpI probe 
 








(Table 4.4 continued) 
Primer   Sequence (5′3′)   Description 
RUG44  GGAGTCGAGCTCTTCATTCC          Used to generate brpK probe (with RUG43) 
RUG173 CGGAACTTATTAATCGAGAC       Used with RUG18 to generate brpC probe 
 
wza-For2 GGTGCTCTACGCGTTAAAACG Used to amplify wzb gene 
wzc-Rev2 GAGTTATCAACGGAAGATCGG 
 
1 From Grau, et al. 2008 (Grau, Henk et al. 2008). 
2 From Garrison-Schilling, et al. 2011 (Garrison-Schilling, Grau et al. 2011). 































CONCLUDING REMARKS AND FUTURE DIRECTIONS 
 
Phase variation in the human pathogen, V. vulnificus, involves the conversion among the 
capsule producing opaque virulent, unencapsulated translucent avirulent, and the biofilm 
proficient rugose phenotypes (Grau, Henk et al. 2005). Though a few studies in the past have 
attempted to identify the environmental triggers (Hilton, Rosche et al. 2006, Garrison-Schilling, 
Grau et al. 2011) and genetic mechanisms causing phase variation (Chatzidaki-Livanis, Jones et 
al. 2006, Grau, Henk et al. 2008) in V. vulnificus, many questions still remain unanswered. Our 
goal in this study was to identify additional environmental factors and genes that lie at the basis of 
phase switching in V. vulnificus. Here, we also focused on elucidating the proteomic differences 
between the virulent opaque and biofilm proficient rugose phenotypes.  
Our study demonstrated that of all the divalent cations tested besides calcium, manganese 
at millimolar levels can induce opaque virulent strains to switch to either the less-virulent 
translucent or biofilm-efficient rugose forms (Figure 2.1, 2.3 – 2.8, 2.10). Our attempt in this study 
was also to identify the genetic components of manganese-induced phase variation in V. vulnificus. 
Our data showed that one of the mechanisms by which translucent colonies arise from opaque 
colonies while subjected to manganese is through deletions in the wzb gene (a tyrosine phosphatase 
involved in capsular polysaccharide chain elongation), caused by homologous recombination 
between the direct flanking repeats adjacent to wzb (Chatzidaki-Livanis, Jones et al. 2006). It 
would be interesting to study how increased Ca2+ and Mn2+ in the growth media could regulate 
genetic recombination events leading to deletion of the wzb gene. However, not all the translucent 
colonies showed this deletion. In fact, the majority of the translucent colonies tested had an intact 






wzb gene would also explain the presence of these translucent colonies with the intact wzb gene.  
Testing if the presence of Ca2+ and Mn2+ could affect transcription of the wzb gene, and elucidation 
of the molecular mechanism involved will also help us better understand the process of Ca2+ and 
Mn2+ induced phase variation in V.vulnificus. Additionally, one of the translucent colonies seemed 
to have an insertion or a duplication event as a longer than predicted band was visible upon PCR 
amplification. It would be interesting to determine the genetic sequence of the wzb locus in this 
strain in order to examine the possible link of this insertion or duplication event to the translucent 
phenotype of the strain.  
Previous studies in our lab showed that an rpoS mutant was unable to phase vary in the 
presence of Ca2+ (Garrison-Schilling dissertation, LSU, 2011).  In our study here, we also saw that 
the rpoS mutant displayed reduced phase variation in the presence of Mn2+ compared to the wild 
type strain. These results indicate that Ca2+ and Mn2+ induced phase variation in V.vulnificus 
appears to involve rpoS. In Pseudoalteromonas sp., RpoS has been shown to suppress the 
expression of mutS (a DNA mismatch repair protein), and therefore increase the frequency of gac 
(two component signal transduction components) mutants, leading to increased phase variation 
(van den Broek, 2005). It would be interesting to study the molecular mechanism of how rpoS is 
involved in Ca2+ and Mn2+ induced phase variation.  Also, the complemented construct created in 
this study did not increase the ability of the mutant to phase vary. This could be because 
overexpression of rpoS, which is a stationary phase stress response regulator in bacteria, might 
affect its functioning in ways unknown. It would only be logical to express rpoS under its 
endogenous promoter and assess if phase variation is restored in the complemented strain in the 






Previous experiments from our lab demonstrated that calcium could enhance phase 
variation and biofilm formation of V. vulnificus (Garrison-Schilling, 2011). However, 
supplementation of calcium to Vibrio parahaemolyticus did not have the same effect (see 
Appendix A, Figure A1-A3).  Here we found that supplementation of the medium with manganese 
also promoted biofilm formation of V. vulnificus.  Of the 3 EPS-related clusters in V. vulnificus, 
the brp and rbd clusters have been shown to have functions in biofilm formation (Grau, Henk et 
al. 2008, Guo and Rowe-Magnus 2010, Guo, 2011, Kim, Park et al. 2009); thus, it would be 
interesting to study whether changes in expression of these genes lie at the basis of manganese- 
and calcium-mediated upregulation of biofilms. In B. subtilis, the simultaneous presence of 
glycerol and manganese has been shown to stimulate biofilm formation. A role for Mn2+ as a 
cofactor has been proposed in this process, wherein it could either act as a cofactor in the binding 
of glycerol to the sensor KinD domain or, it could act as a cofactor for SpoOF, a sporulation factor, 
enhancing the downstream signal phosphorelay (Shemesh and Chai 2013). One cannot deny the 
possibility of Mn2+ acting as cofactor for proteins involved in the process of biofilm formation in 
V.vulnificus. Additionally, changes in levels of Mn2+ in the growth medium have been shown to 
alter the activity of a Mn2+ binding regulator, PsaR, which further affects gene expression by 
altering the levels of RNA transcripts of several genes in S. pneumoniae (Johnston, Briles et al. 
2006). There is also a possibility that Mn2+ may regulate expression of genes involved in biofilm 
formation in V.vulnificus as previously seen in S. mutans, where, SloR, which is a Fe3+- Mn2+ 
transcriptional metalloregulator, influences genes affecting sucrose dependent and sucrose 






Here, we also attempted to study the dual effect of temperature and media composition on 
V. vulnificus phase variation. Our data showed that both translucent and rugose colonies were 
observed at 30°C in LB2, LB2+Ca and LB2+Mn. Though LB2 and LB2+Mn showed propensity 
to switch to translucent colonies at 37°C, no such relationship was seen in LB2+Ca (see Appendix 
B, Figure B1- B3) and further studies need to be performed to decipher the different results 
observed.  
The results from the two dimensional gel electrophoresis (2DGE) and mass spectrometry 
(MS) experiments identified several proteins whose expression either increased, decreased or was 
solely observed in the rugose phenotype (Table 3.1). One of the proteins identified by mass MS 
and Swiss Prot analysis to be increased in the rugose phenotype was MalE (maltose binding 
periplasmic protein). Since phase variation in V. vulnificus is characterized by changes in surface 
polysaccharide expression, we chose to study the role of malE (VVA0397) in the rugose phenotype 
and biofilm formation in V. vulnificus. The increased expression of MalE protein (Table 3.1) along 
with the transcriptional upregulation of malE (Figure 3.2) in the rugose phenotype was very 
interesting as it has been previously shown that maltose inhibits biofilm formation in V. cholerae 
(Ali, Morris et al. 2005). Also, it has been demonstrated in V. vulnificus that the presence of 
maltose in the medium does not induce biofilm formation (Kim, Park et al. 2009). The seemingly 
contradictory nature of our 2DGE, RNA dot blot results and the published literature led us to 
construct a malE mutant, which would help to dissect the role of malE in V. vulnificus biofilm 
formation and the rugose phenotype. Interestingly, the malE mutant generated retained the rugose 
phenotype indicating that malE is not required for the rugosity phenotype of V. vulnificus under 






transcript was increased in the rugose phenotype suggests a role for the MalE in the same. Since, 
we did not observe the expected non rugose phenotype in the malE (VVA0397) mutant, it is 
possible that there exists another protein which compensates for the loss of malE function. In fact, 
there exists the gene VVA0056 (protein Q7MGB3), which is also designated as coding for a 
maltose binding periplasmic protein in the genome of YJ016 and is 56 % identical in amino acid 
composition to the VVA0397 product. Construction of a double mutant would further address the 
potential role of MalE and its paralogs in rugosity.  
There is also the possibility that maltose or a maltodextrin, which are sugars transported 
by the maltose transport system could act as a signal for rugose colony or biofilm formation. This 
can be assessed by supplementation of these sugars to the medium to observe if an opaque colony 
can develop rugosity. Alternatively, it is possible that maltose and/or a maltodextrin could form 
an integral part of the exopolysaccharide (EPS) matrix. The composition and structure of the V. 
vulnificus EPS can be determined by polysaccharide analysis of the rugose matrix by using a 
combination of nuclear magnetic resonance (NMR), chromatography and mass spectrometry (MS) 
(Yildiz, Fong et al. 2014). In addition to substrate translocation, MalE proteins can also play roles 
in signal recognition in chemotaxis (Ehrmann, Ehrle et al. 1998) and as chaperones Richarme, 
1997).  
In addition to the MalE protein, our study identified a number of proteins like adenosine 
deaminase, alanine racemase, pantothenate synthase, Clp proteases, and a hypothetical 
uncharacterized protein (VVA0984 gene product), whose production was increased in the rugose 
phenotype compared to the opaque and it would be interesting to study the role of these proteins 






Lastly, we showed that the brp locus, which functions in exopolysaccharide biosynthesis 
and transport (Grau, Henk et al. 2008, Guo and Rowe-Magnus 2010), is very well conserved in 
both the previously existing strains in the laboratory as well as the newly isolated V. vulnificus 
strains from the environment. Though the PCR results showed that all the wcr genes were present 
in all but one of the 42 previously existing and new strains tested, some of the newly isolated 
strains exhibited a different 2.7 kb restriction fragment length polymorphism (RFLP) in addition 
to the expected 10.5 kb band. Despite the different 2.7 kb RFLP profile the ability of such strains 
to form rugose colonies was retained indicating that mutations taking place at this locus could be 
silent. Sequencing of the genetic loci of some of these strains harboring the alternate RFLP profile 
will help us determine the nature of genetic changes occurring here.  
Overall, the findings presented in this study not only resulted in a better understanding of 
the processes of phase variation and rugose colony formation in V. vulnificus, but they also are a 
step forward towards potential applications to better control human diseases caused by V. 
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EFFECT OF CALCIUM ON V. PARAHAEMOLYTICUS PHASE VARIATION 
 
Vibrio parahaemolyticus is a close relative of Vibrio vulnificus and is a leading cause of 
gastroenteritis in the United States. As observed in V. vulnificus, the opaque and translucent 
phenotypes have also been reported in V. parahaemolyticus and exhibit phase variation from one 
phenotype to the other (McCarter 1998, McCarter 1999).  
Since previous studies in our lab indicated that V. parahaemolyticus strain ATCC17802 
does not undergo phase variation in the presence of calcium, we wanted to test if this is simply a 
strain-specific phenomenon or whether calcium does not generally affect phase variation in V. 
parahaemolyticus.  We therefore performed switching assays on V. parahaemolyticus strains 
ATCC17802, ATCC33847 and ATCC49529 in LB2 and LB2 supplemented with 1 mM calcium. 
Switching assays were carried out as previously described (Garrison-Schilling, 2011).  
Strain ATCC17802, as previously observed in the presence of LB2+Ca, did not show any 
significant translucent or rugose colonies at all passages tested. In fact switching to 14.9 ± 14.0 % 
and  54.9 ± 34.4 % translucent phenotype was seen after 10 and 15 passages in LB2 (Figure A1).  
Strain ATCC33847 showed switching to predominantly 6.6 ± 7.9 %, 18.8 ± 17.1 % and 
19.4 ± 11.3 % rugose colonies after 5, 10, 15 passages in LB2. Also little switching to 5.7 ± 13.7 
% translucent colonies was observed after the 15th passage in LB2. However, in the presence of 
calcium 16.2 ± 16.1 % rugose colonies were seen after 15 passages but no switching was observed 










Figure A1: Response of V.parahaemolyticus strain ATCC17802 to increased calcium. Switching 
assays were carried out in LB2 and LB2+Ca. Phase variation was assessed at passages 5,10,15 by 
plating on LB2 agar. The proportion of different phenotypes was calculated for 6 independent 
experments and means and standard deviations are presented here.  
 
 
Figure A2: Response of V.parahaemolyticus strain ATCC33847 to increased calcium. Switching 
assays were carried out in LB2 and LB2+Ca. Phase variation was assessed at passages 5,10,15 by 
plating on LB2 agar. The proportion of different phenotypes was calculated for 6 independent 










































Strain ATCC49529 showed very little switching to 2.5 ± 6.0 % , 1.8 ± 2.2 % , 6.1 ± 5.7 % 
translucent colonies after 5, 10, 15 passages respectively and 2.5 ± 6.1 % , 1.4  ± 1.2 %  rugose 
colonies after passage 10 and 15 in LB2. However, in the presence of calcium, scant switching to 
0.1 ± 0.3 %,  0.3 ± 0.8 % translucent and  0.3 ± 0.6 % , 0.2 ± 0.5 % rugose colonies was observed 
after passage 10 and 15, respectively (Figure A3).  
 
Figure A3: Response of V.parahaemolyticus strain ATCC49529 to increased calcium. Switching 
assays were carried out in LB2 and LB2+Ca. Phase variation was assessed at passages 5,10,15 by 
plating on LB2 agar. The proportion of different phenotypes was calculated for 6 independent 
experments and means and standard deviations are presented here.  
 
These results from the switching assays indicated that calcium seems to reduce phase 
variation in V.parahaemolyticus and different strains exhibit different patterns of switching to 



























SIMULTANEOUS EFFECT OF CHANGING TEMPERATURE AND ADDITION OF 
DIFFERENT DIVALENT CATIONS ON V. VULNIFICUS PHASE VARIATION 
 
Temperature has been shown to influence phase variation in V. vulnificus (Hilton, 2006). 
Also, previous studies in our lab demonstrated that of all the temperatures tested i.e. 15°C, 20°C, 
25°C, 30°C and 37°C, maximum phase variation of strain 1003(O) occurred to 72.0 ± 38.7 % 
translucent colonies at passage 15 in  HI medium at 30 °C (J. Finley and G.S. Pettis, unpublished 
results). Switching frequencies at other temperatures were lower than that seen at 30°C. At 37°C 
and 25°C switching occurred to the translucent form at a frequency of 2.5 ± 3.8 % and 2.2 ± 1.0 
% respectively. At 20°C, 0.2 ± 0.2 % translucent colonies were observed, whereas no switching 
was observed at 15°C. This data indicated that phase variation in V. vulnificus occurs in a specific 
temperature range. Previous data regarding calcium supplementation (Garrison-Schilling, 2011) 
and our current data regarding manganese have indicated that addition of these to the media results 
in CPS or EPS phase variation in V. vulnificus. We therefore wanted to study if changes in 
temperature and cation simultaneously affect phase variation. Switching assays were performed 
on strain 1003(O) in the presence of LB, LB2+Ca or LB2+Mn each at 30°C and 37°C. 
  Switching assays in LB2 at 30°C seems to bring about phase variation to both 34.9 ± 50.0 
% translucent and 25.3 ± 43.3 % rugose colonies after 15 passages. However, switching assays at 
37°C in LB2 brings about phase variation to predominantly 14.4 ± 17.1 %, 70.5 ± 44.0 %, 97.0 ± 











Figure B1: Effect of changing temperature on V. vulnificus strain 1003(O) in LB2 medium.  
Switching assays were perormed as mentioned above and colonies counted after ON, 5, 10, 15 
passages. Data presented here are averages and standard deviations of 3 independent experiments.  
 
In the presence of calcium at 30°C, phase variation to both translucent (max 50.6 ± 12.8 % 
at passage 10) and rugose (max 44.8 ± 33.1 % at passage 5) colonies was seen at all passages. At 
37°C, rugose colonies were seen at all passages (max 50.9 ± 41.6 % at passage 5). Even though 
37.9 ± 28.9 % translucent colonies were observed at passage 5, their numbers dwindled with each 
successive passage (12.0 ± 18.8 %, 0.3 ± 0.2 % at passages 5, 10 respectively) (Figure B2).  
 In the presence of manganese at 30°C, phase variation was seen to mostly 97.2 ± 1.0 %, 
44.0 ± 49.8 %,  98.3 ± 1.3 % translucent colonies at 5, 10, 15 passages respectively. 52.4 ± 49.5 
% rugose colonies were also seen at passage 10. However at 37°C exclusively 88.4 ± 13.8 %, 79.6 





























Figure B2: Effect of changing temperature on V. vulnificus strain 1003(O) in LB2+Ca medium.  
Switching assays were performed as mentioned above and colonies counted after ON, 5, 10, 15 





Figure B3: Effect of changing temperature on V. vulnificus strain 1003(O) in LB2+Mn medium.  
Switching assays were performed as mentioned above and colonies counted after ON, 5, 10, 15 
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Our preliminary data from LB2 and LB2+ Mn at 37 °C shows that there is a propensity for 
strain 1003(O) to switch from opaque to the translucent phenotypes. In the presence of LB2+Ca at 
37°C, though both translucent and rugose colonies are seen at passages 5 & 10, the number of 
translucent colonies decrease successively. However, at 30°C, both rugose and translucent 
colonies were seen in all media though at different time points during the switching assays (passage 
15 in LB2, all passages in LB2+Ca and passage 10 in LB2+Mn).  Further work needs to be 
undertaken to discern these differences observed due to the dual effects of temperature and media 







SUPPLEMENTARY DATA FOR CHAPTER 3 
 
Table C1: Mass spectrometry results of proteins identified to be differentially expressed between the rugose and opaque V.vulnificus 
phase variants using Peaks, PLGS or MASCOT software. 
 
PDQuest       Hits    Organism                Accession    MW        pI      Coverage   MASCOT                   Peptide sequence 
Spot #         number         (Da)                     %             score                                                                                      
1502             No hits     -                  -             -     -        -                   -                                                                       -                         
1503          Polar    V. parahaemolyticus    Q56702     39,824    4.67      14.36           -                                               AAGLQISNRb 
          flagellin A                                                        (R)IAETTSFGGNK(L)a,b        
                                        (K)DDAAGLQISNR(L) a,b      
                                     AINVNTNVSAM[2]TAQRb           
                               (K)SQILQQASTSILAQAK(Q) a         
                                         (R)VAIQEEVTALNDQLNR(I) a    
         Phospho-   V.vulnificus                  Q8DCA0    40,811   4.63       5.18              -                                 (K)LTVLESLSK(I) a,b 
         - glycerate                                -                          (K)AFDENAEAEIK(H) a,b 








(Table C1 continued) 
PDQuest  Hits     Organism Accession    MW        pI      Coverage   MASCOT                  Peptide sequence 
Spot #     number        (Da)                          %            score                                                                                      
     PAVEM[2]LEARb 
1601 No hits        -                    -                    -             -           -                   -                                                                                   - 
 
1602 Polar      V.     Q56712        40,787     4.38       15.11         -                                              (R)IAETTSFGGR(R) a,b 
 flagellin C     parahaemolyticus                    -                                          (K)DDAAGLQISNR(L) a,b 
                                                                                                                      -                   (R)LSHSINNLANVQENVDASNSR(I) a 
                      
                              -                                      AVTVSTNVSAM[2]TAQRb 
                   -                             (K)AQILQQAGTSILAQAK(Q) a,b 
2510 Adenosine     V.vulnificus   Q8D6Q8     36,959     4.72       32.33        -                                               (R)FGPLLHQVK(G) a,b 
 deaminase                                       -                                                   (-)MNYFDLPK(I) a,b 
                              -                                        (K)DGIAVTINTDNR(T) a,b 
                   -                             (R)AEAQYDIHGNYILSILR(T) a,b 








(Table C1 continued) 
PDQuest       Hits    Organism Accession    MW        pI      Coverage   MASCOT                   Peptide sequence 
Spot #     number        (Da)                          %            score                                                                                      
-                             (R)ISFELFEDAANENVK(Y) a,b 
-                       (K)GEEVALETCPSSNVQTK(A) a,b 
                      -                         (R)FELPGMMMQTAEALER(I) a,b 
                      -                                    PQTIIDLADEQNLTLPSR b 
                      -                        AGEQGAGQNVYDAISLLGAER b  
  
2601          Polar    V.        Q56702     40,148    4.70      43.39             -                                            (K)LQIFAGNNK(V) a,b 
         flagellin    parahaemolyticus                                -                                            (R)AELGAFQNR(F) a,b 
          B/D         -                              (K)SQILSQASSSILAQAK(Q) a 
            -                                        (R)IAETTSFGGNK(L) a,b 
           -                                       (K)DDAAGLQISNR(L) a,b 
              -                           (R)VAIQEEVTALNDELNR(I) a,b 








(Table C1 continued) 
PDQuest       Hits    Organism Accession    MW        pI      Coverage     MASCOT                                           Peptide sequence 
Spot #     number        (Da)                          %             score                                                                                      
           -                      (R)FNHAISNLDNINENVNASK(S) a 
                                                                                                                        -                    (R)FNHAISNLDNINENVNASK(S) a,b 
                                                                                                                                   -                            (-)AVNVNTNVSAMTAQR(Y) a,b 
                     -                            (-)AVNVNTNVSAMTAQR(Y) a,b 
                                -                               (K)SQILSQASSSILAQAK(Q) a 
                      -                                        AISNLDNINENVNASKb 
                      -                           (R)YLNNANSAQQTSMER(L) a,b 
                      -   (R)NANDGISIAQTAEGAMNETTNILQR(M)a,b 
                                 -                           (R)VAIQEEVTALNDELNR(I) a,b 
                                            -                   (R)FNHAISNLDNINENVNASK(S) a,b 
                      -               (K)AGDDIEELATYINGQTDLVK(A) a,b 
    
            Phospho-   V.   Q8DCA0       40,718     4.55      28.24            -                                                 (R)IIASLPTIK(L)a,b 








(Table C1 continued) 
PDQuest       Hits    Organism Accession    MW        pI      Coverage   MASCOT                 Peptide sequence 
Spot #     number        (Da)                          %          score                                                                                      
  kinase                                    -                                                     PAVEM[2]LEARb 
           -                        (K)AMSNPERPLVAIVGGSK(V) a,b 
                                           -                                        (K)AFDENAEAEIK(H) a,b 
                                -                                      (K)VLPAVEMLEAR(A) a,b 
           -                                             AGPLLAAELEALGKb  
           -                                   (K)SLYEADLVETAQK(L)a,b                         
                     -                                     (K)SLYESDLVETAQK(L)a 
                                -                                (K)TILWNGPVGVFEFK(N) a,b 
                     -   (K)IADQLVVGGGIANTFIAAEGHNVGK(S) a,b 
3504 Pantothenate   V.vulnificus      Q7MHV3    33,587    4.83         7.31             -                                           (R)ADDLNNYPR(T) a,b 
Synthetase         -       (R)LIDNQVVELVK(D) a,b 
                                                   -                     (-)MQTFAEISALR(E) a,b 








 (Table C1 continued) 
PDQuest       Hits    Organism Accession    MW        pI      Coverage    MASCOT                   Peptide sequence 
Spot #     number        (Da)                          %             score                                                                                      
4208 Putative amino   V. harveyi     P52626        27,481     5.25       27.42           -                                (K)TYDTGIEHDVALGR(A) a,b 
             acid ABC                                  -                                                (R)YFPFTFVK(Q) a,b 
 transporter                                           -                                                  DTGIEHDVALGRb 
binding protein                          -                                                   FSGLFGLLETGRb  
           -                                  (K)TYDTGIEHDVALGR(A)a 
                     -                                  (R)IDTISNQITMTDAR(K) a,b 
                      -                             (K)TVAVNLGSNFEQLLR(D) a,b 
                     -                       (K)YLFADPYVVDGAQITVR(K) a,b  
4805 Sulfite     V.vulnificus   Q7MHA5|     67,239       4.93     27.44         -                                               QKPYAATLLTSQKb 
            reductase                 CYSJ_VIBVY                                    -                                                 (K)LGATPFIER(V)a 
 flavoprotein                                          -                                                         AEALEQEAKb 
alpha-component                         -                       (K)LGATPFIER(V)a,b 








(Table C1 continued) 
PDQuest       Hits    Organism Accession    MW        pI      Coverage      MASCOT                                          Peptide sequence 
Spot #     number        (Da)                        %                 score                                                                                      
-                                      (R)FGGASGYLAQR(L) a,b  
-            (K)GVAEALEQEAK(A) a,b 
             -                                                                               PYAATLLTSQKb        
                                                                                                                                    -                                       (K)LTAEELVGLLR(R) a,b 
                                                     -                                         (K)VFVENNNNFK(L) a,b 
                        -                               (K)LTAEELMGLLR(R) a 
                      -                              (R)GDAEEFINDLR(K) a,b 
                      -                          (K)LTIIFASQTGNAK(G) a,b 
                                                                                                                                    -                                    (K)QKPYAATLLTSQK(I) a 
                      -                         (K)QKPYAATLLTSQK(I) a,b 
                                            -           (K)LPADDNVPVIMVGPGTGIAPFR(S) a,b 
                                                                                                                    -               (K)FEITSSNPQQVEK(F) a,b 
                         -                            (K)AEGIAVQLFDASDYK(G) a,b 







(Table C1 continued) 
PDQuest    Hits    Organism Accession    MW        pI     Coverage      MASCOT                                          Peptide sequence 
Spot #     number        (Da)                     %                  score                                                                                      
                                  -                         (R)EYAGNTQLVDLLAEK(Q) a,b 
                                             -                            (R)EYSGNTQLVDLLAEK(Q) a 
                                                                                                                                     -          (K)LPADDNVPVIMVGPGTGIAPFR(S) a,b 
5403       Elongation      V.vulnificus   Q7MIG1   29,923     5.10     5.36                 -                          (K)IGVVVAGEGDAETLK(H) a,b 
       factor Ts 
      Glyceraldehyde  Escherichia  P0C8Z1 31,384     5.97     8.16                 -                                          (K)KVVLTGPSK(D) a,b 
      3 phosphate           fergusonii         
      dehydrogenase    
                  A fragment                          
7602       No hits           -                                   -                -            -                     -                                                                              -                         
7710      Alanine           V.                  Q8D6Q0   44,078   5.72     6.13                -                                        (K)AQVLINGQR(A) a,b  
                 racemase 2           vulnificus                                        (R)NGIDMSTER(G) a,b                         
   -                                        (R)ESGFEGELIR(V) a,b 







(Table C1 continued) 
PDQuest       Hits    Organism Accession    MW        pI      Coverage      MASCOT                                         Peptide sequence 
Spot #     number        (Da)                          %                score                                                                                      
                                                                                                                             -                                             PGDEVTLFGAQKb 
                            -                       (K)GVLPGDEVTLFGAQK(N) a,b 
1616 Putative              V.vulnificus    Q8DD27   33,196      4.31         3.63     -                                   (K)VGDEVAIVGIK(D) a,b 
 elongation factor                
 Tu like protein 
1505 Maltose              E.aerogenes     P18815     43,109       9.07        6.82              48                                           GYNGLAEVGKa,b,c 
 binding periplasmic protein 
2708 Argino-              V.vulnificus     Q7MH72   44,476      4.68       16.87             75                                      EELVADYIYPTLKa,b,c 
-succinate synthase                      98                                ASGASECYVVDLKa,b,c 
                     86                                 FEGAFAALAPDLKa,b,c 
                                                                                                                                       64                                            EQCLDYLAERa,b,c 
                                                                                                                                     11                                               NIPCAASLTKa,b,c 








(Table C1 continued) 
PDQuest       Hits    Organism Accession    MW        pI      Coverage      MASCOT                                          Peptide sequence 
Spot #     number        (Da)                          %                 score                                                                                      
            ATP synthase  V.vulnificus     Q7MG10    50,691      4.63        18.42             22                              QLDPLVVGQEHYDTARa,b,c 
 subunit beta                               62                          GVEVVNTGAPISVPVGTKa,b,c 
                                  52                                LVLEVQQQLGGGVVRa,b,c 
                       62                                     YTLAGTEVSALLGRa,b,c 
                        64                                          IMNVLGDAIDERa,b,c 
                                                                                                                                     55                                               VALTGLTMAERa 
 Trigger factor   V.vulnificus     Q7MMG8   48,280    4.61        2.78  57                                          FGVAEGGIDALKa,b,c 
3706 No hits                     -                    -                  -             -              -                 -                                                                                - 
4206 ATP                   V.vulnificus      Q7MMG7    21,986   5.00        18.5            32                              R.LLAEHTGQPIEVIER.Da,b,c 
dependent Clp                                                                     82              DNFMSADQAVEYGLVDAVLTHRa,b,c 
proteolytic subunit        89                                      LLAEHTGQPIEVIERa,b,c  









(Table C1 continued)  
PDQuest       Hits    Organism Accession    MW        pI      Coverage      MASCOT                                          Peptide sequence 
Spot #     number        (Da)                          %                 score                                                                                      
 Uracil        V.vulnificus          Q7MIK2    22,721    5.34          11.54                35                              VLVLVAAPEGIEALEKa,b,c 
             phosphoribosyl-                         25                                GYIVPGLGDAGDKa,b,c 
 -transferase                                  48                                                    ISVVGIYRa,b,c 
4509 o Succinyl-        V.fischeri  B5FFK8    36,104     4.28           2.47    51                                                    VGLYEPIRa,b,c 
 - benzoate synthase 
6809 Putative              V.vulnificus   Q8DD27   33,196 4.31          6.93               62                              IVELAEALDSYIPEPERa,b,c 
elongation factor             53                                       VGDEVAIVGIKa,b,c 
Tu like protein                      48                                            AGENVGALLRa,b,c 
Ninein like    Homo sapiens   Q9Y2I6   156,247    4.82         0.58              41                                                    LQAIQEERa,b,c 
protein 
7306    Putative              V.vulnificus      Q7MFN1  27,387     5.54        26.91            37                                 VITHSPSQFLDFLELRa,b,c 
 hydrolase                       87                            LDLASELLDSVGIDSHRa,b,c 
                                    46                                EAHTQALLNVIQGGRa,b,c 







(Table C1 continued)  
PDQuest       Hits    Organism Accession    MW        pI      Coverage      MASCOT                                          Peptide sequence 
Spot #     number        (Da)                          %               score                                                                                      
      75                                                   FLEGVAILRa,b,c 
7510  Flagellar P       V.vulnificus      Q7MMV0   37,896    7.32     20.66            82         MADAVNNFLGPQMASAVDATSVRa,b,c 
  ring protein                     52                          IVGNNPTVGIISSGAMVERa,b,c 
                   
                                  72                                           FEPGLTLDDLVRa,b,c 
                                  72                                           IKDVAQVAGVRa,b,c 
                                     47                                               GGTLLQTFLKa,b,c 
5205 UPF0319           V.vulnificus    Q7MMT3   28,260   5.57            6.12           75                                SVLDFDNGLNQLVVRa,b,c 
             protein VV0984                                                                         37                       K.LSQSIAEQPIVEMEK.Ga,b,c 
5309     Ribosomal        V.vulnificus     Q8D8X2      26,575   5.11           23.18          48                                  IGAIELDESLEPGEYRa,b,c 
 small subunit                       63                                        SGEVTVNEQVQKa,b,c 
             pseudouridine                                                                      45                                              FLCDALGATRa,b,c 
 synthase A                      32                                                   LAEGVQLRa,b,c 








(Table C1 continued)  
PDQuest       Hits    Organism     Accession    MW        pI      Coverage     MASCOT                  Peptide sequence 
Spot #          number        (Da)                      %               score                                                                                      
 Ribonuclease PH   V. vulnificus   Q7MPT3   25,549   5.07         4.20             60                                                GISEIVAAQKa,b,c 
5604 Coenzyme             V.vulnificus     Q7MPS9   42,980   5.15    13.72  55                                       TDDSDEMTITMVKa,b,c 
 A biosynthesis              78                                        NVATQENIATLSRa,b,c 
 bifunctional protein             43                             K.ILLGISGGIAAYK.Ca,b,c 
 CoaBC             42                                            GAEVQVVMTKa,b,c   
                46                                                  SILITAGPTRa,b,c 
               37                                            AALSMEILKa,b,c 
5404      No hits                          -                      -            -           -              -                  -                                                                              - 
1108   No hits                         -                       -            -           -              -                  -                                                                              -                         
6808   Ninein                   Homo            Q9Y216     156,247   4.82         0.58            41                                                   LQAIQEERa,b,c 
   like protein           sapiens 
   Transcription        A.                   O64647      37,607     9.90         3.37           40                                      LEEVAGKDQTLRa,b,c 








(Table C1 continued)  
PDQuest       Hits    Organism Accession    MW        pI      Coverage      MASCOT                   Peptide sequence 
Spot #     number        (Da)                          %               score                                                                                      
7301     Dethiobiotin   V.vulnificus   Q7MLU7    24,621    5.42       32.6         51                           VNPGTEHYAEIIDMLEERa,b,c  
      synthase                63                                 QEDLPVVLVVGIKa,b,c 
               49                                  AFFIAGTDTDVGKa,b,c 
               60                                          LGEIPYIPSAKa,b,c 
               65                                          VEIDYAVLSRa,b,c 
               58                          R.TIGYKPVAAGSDK.Ta,b,c 
a: analyzed by PLGS 
b: analyzed by Peaks 
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